本文へ

当サイトでは、利用測定やトラフィック分析を目的として、クッキー(Cookie)を利用しています。
「同意する」ボタンや本サイトをクリックすることで、クッキーの利用に同意いただいたことになります。
詳しくはプライバシーポリシー別ウィンドウで開くをご覧ください。

同意する

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. ホーム
  2. 臨床研究
  3. 研究実績

研究実績

論文

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study

Momoko Tokura, Mark Malaly Ando, Yuki Kojima, Rui Kitadai, Shu Yazaki, Cyrielle Marie N Atutubo, Rubi K. Li, Minda Z. Perez, Agnes E Gorospe, Manuelito A Madrid, Mel Valerie C Ordinario, Marcelo Severino B Imasa, Kazuki Sudo, Tatsunori Shimoi, Akihiko Suto, Shinji Kohsaka, Ryunosuke Machida, Ryo Sadachi, Masayuki Yoshida, Yasushi Yatabe, et al.

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial

Kato K, et al.

Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons. Gastroenterology. 2023; 164: 293-5.

Sekiguchi M, Westerberg M, Ekbom A, et al.

First-in-human study of ONO-4578, an antagonist of prostaglandin E(2) receptor 4, alone and with nivolumab in solid tumors. Cancer Sci, 2022

Iwasa S, Koyama T, Nishino M, Kondo S, Sudo K, Yonemori K, Yoshida T, Tamura K, Shimizu T, Fujiwara Y, Kitano S, Shimomura A, Sato J, Yokoyama F, Iida H, Kondo M, Yamamoto N

Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study

Yoshiaki Usui, Hidemi Ito, Yuriko Koyanagi, Akiko Shibata, Tomohiro Matsuda, Kota Katanoda, Yoshinobu Maeda, Keitaro Matsuo

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan. JAMA Netw Open 5:e2245081, 2022

Naito Y, Sunami K, Kage H, Komine K, Amano T, Imai M, Koyama T, Ennishi D, Kanai M, Kenmotsu H, Maeda T, Morita S, Sakai D, Watanabe K, Shirota H, Kinoshita I, Yoshioka M, Mamesaya N, Kohsaka S, Yoshino T, et al.

Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice. Cancer Sci 113:4300-4310, 2022

Ida H, Koyama T, Mizuno T, Sunami K, Kubo T, Sudo K, Tao K, Hirata M, Yonemori K, Kato K, Okusaka T, Ohe Y, Matsui Y, Yamazaki N, Ogawa C, Kawai A, Narita Y, Esaki M, Yamamoto N

Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information. Exp Hematol Oncol 11:82, 2022

Hamamoto R, Koyama T, Kouno N, Yasuda T, Yui S, Sudo K, Hirata M, Sunami K, Kubo T, Takasawa K, Takahashi S, Machino H, Kobayashi K, Asada K, Komatsu M, Kaneko S, Yatabe Y, Yamamoto N

Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors. Nat Commun. 2022 Sep 24;13(1):5614.

Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, Navin R Mahadevan, Joao V Alessi, Yin P Hung, Arrien A Bertram, David E Heppner, Mauricio F Ribeiro, Karina P Sacardo, Rodrigo Saddi, Mariana P Macedo, Rafael B Blasco, Jiaqi Li, Kari J Kurppa, Tom Nguyen, Emma Voligny, Guruprasad Ananda, Roberto Chiarle, Pasi A Jänne , et al.

Practical consideration for successful sequential tumor biopsies in first-in-human trials. Invest New Drugs 40:841-849, 2022

Koyama T, Shimizu T, Sato J, Katsuya Y, Iwasa S, Kondo S, Yoshida T, Sudo K, Nishino M, Takiguchi Y, Yonemori K, Yamamoto N

Phase I study of the irreversible FGFR1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors

Toshihiko Doi, Kohei Shitara, Takashi Kojima, Yasutoshi Kuboki, Nobuaki Matsubara, Hideaki Bando, Kiyotaka Yoh, Yoichi Naito, Hiroshi Hirai, Yukinori Kurokawa, Terufumi Kato, Chigusa Morizane

Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan

Tom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, Yu-Chun Hsieh, Antoine Italiano, Ya-Wen Yang, Nicolas Penel, Wen-Chung Lee, Emmanuelle Bompas, Thibaud Valentin, Philippe Anract, Nelly Firmin, Florence Duffaud, Ann-Lii Cheng, Francoise Ducimetiere, K Arnold Chan, Jean-Yves Blay

Spontaneous tumour lysis syndrome as a rare presentation of thymoma with peripheral blood lymphocytosis

Larry E Nyanti, Andy Sing Ong Tang, Adam Malik b Ismail, Lee Ping Chew, Tze Shin Leong

Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)

Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, Tu V Dao, Daniel Castellano, Jian-Ri Li, Som D Mukherjee, Kathryn Howells, Hannah Dry, Mark C Lanasa, Ross Stewart, Dean F Bajorin

Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial

Akihiro Ohba, Chigusa Morizane, Makoto Ueno, Satoshi Kobayashi, Yasuyuki Kawamoto, Yoshito Komatsu, Masafumi Ikeda, Mitsuhito Sasaki, Naohiro Okano, Junji Furuse, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka

Impact of the COVID-19 pandemic on population-based cancer registry

Isabelle Soerjomataram, Aude Bardot, Joanne Aitken, Marion Piñeros, Ariana Znaor, Eva Steliarova-Foucher, Betsy Kohler, Manola Bettio, Tomohiro Matsuda, Marianna de Camargo Cancela, Les Mery, Freddie Bray

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study

Jirawat Thanestada, Varalak Srinonprasert, Akarin Nimmannit, Krittiya Korphaisarn, Pornpoj Pramyothin, Charuwan Akewanlop

Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

Margarita Majem, Jonathan W Goldman, Thomas John, Christian Grohe, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, Huu Vinh Vu, Shun Lu, Shanqing Li, Kye Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Shinji Atagi, Lingmin Zeng, Yi-Long Wu

Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories. J Breast Cancer . 2022 Jun;25(3):207-217.

Ithimakin S, Parinyanitikul N, Kim SB, Yap YS, Tsang J, Soong IS, Ozaki Y, Ohno S, Ono M, Chan JJ, Cheng HC, Dejthevaporn T

Treatment for postoperative recurrence of pancreatic cancer: a narrative review

Takuji Okusaka

Impact of bodyweight-based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma

Takuji Okusaka, Masatoshi Kudo, Kenji Ikeda, Masafumi Ikeda, Kiwamu Okita, Michiko Sugawara, Toshiyuki Tamai, Min Ren, Kenichi Saito, Hiromitsu Kumada

Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort

Tu Van Dao, Tuan Bao Diep, Tri Le Phuong, Reto Huggenberger, Amit Kumar

Gestational trophoblastic neoplasm in a patient with end-stage renal failure (ESRF): the challenges and lessons learnt.

Kanddy Chin Yee Loo, Yueh Ni Lim, Doreen Kher Lee Kiu, Wee Wee Sim

Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors. Clin Cancer Res 28:1783-1791, 2022

Sato J, Shimizu T, Koyama T, Iwasa S, Shimomura A, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Tamura K, Suzuki T, Takase T, Nagai R, Yamaguchi K, Semba T, Zhao ZM, Ren M, Yamamoto N

Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer

Patrapim Sunpaweravong, Patcharaporn Thongwatchara, Rassamee Chotipanvithayakul, Surasak Sangkhathat, Paramee Thongsuksai

Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Shuhei Nomura, Haruka Sakamoto, Cyrus Ghaznavi, Manami Inoue

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer. Nat Cancer. 2022 Apr;3(4):402-417.

Ciric To, Tyler S Beyett, Jaebong Jang, William W Feng, Magda Bahcall, Heidi M Haikala, Bo H Shin, David E Heppner, Jaimin K Rana, Brittaney A Leeper, Kara M Soroko, Michael J Poitras, Prafulla C Gokhale, Yoshihisa Kobayashi, Kamal Wahid, Kari J Kurppa, Thomas W Gero, Michael D Cameron, Atsuko Ogino, Pasi A Jänne, et al.

Metastatic Primary Testicular Neuroendocrine Carcinoma Associated with Somatic Malignant Transformation of Teratoma: A Rare Case Report.

Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Kanet Kanjanapradit, Arunee Dechaphunkul

Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers. Nature. 2022 Mar;603(7900):335-342.

Yoshihisa Kobayashi, Chhayheng Chhoeu, Jiaqi Li, Kristin S Price, Lesli A Kiedrowski, Jamie L Hutchins, Aaron I Hardin, Zihan Wei, Fangxin Hong, Magda Bahcall, Prafulla C Gokhale, Pasi A Jänne

Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation. Ther Innov Regul Sci 56, 220–229 (2022).

Kenichi Nakamura, Hitoshi Ozawa, Taro Shibata, Nobuko Ushirozawa, Tomomi Hata, Natsuko Okita, Nozomu Fuse, Norihiro Sato, Koji Ikeda, Hideki Hanaoka, Tatsuya Maruyama, Michihiko Wada, Shinobu Shimizu, Hiroi Kasai, Yoichi Yamamoto, Jun Sakurai, Koji Todaka, Shimon Tashiro, Haruko Yamamoto

Efficacy and safety of ceritinib 450 mg/d with food and 750 mg/d in fasted state in treatment-naïve patients with ALK+ non-small cell lung cancer: Results from the ASCEND-8 Asian subgroup analysis. Cancer Res Treat. 2022 Mar 25.

Byoung Chul Cho, Pei Jye Voon, et al.

Clinical Characteristics of Pancreatic and Biliary Tract Cancers Associated with Lynch Syndrome. J Hepatobiliary Pancreat Sci (Oct 24 2021).

Takamizawa Shigemasa, Morizane Chigusa, Tanabe Noriko, Maruki Yuta, Kondo Shunsuke, Hijioka Susumu, Ueno Hideki, Sugano Kokichi, Hiraoka Nobuyoshi, Okusaka Takuji

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

Sook-Yee Yoon, Rozita Abdul Malik, Soo Hwang Teo, et al.

Clinical significance of discordances in sentinel lymph node reactivity between radioisotope and indocyanine green fluorescence in patients with cN0 breast cancer

Kenjiro Jimbo, Uta Nakadaira, Chikashi Watase, Takeshi Murata, Sho Shiino, Shin Takayama, Akihiko Suto

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Yi-Long Wu, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Sang-We Kim, Terufumi Kato, Konstantin Laktionov, Huu Vinh Vu, Zhijie Wang, Shun Lu, Kye Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Lingmin Zeng, Ajlan Atasoy, et al.

Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System

Shinichi Yachida, Yasushi Totoki, Michaël Noë, Yoichiro Nakatani, Masafumi Horie, Kenta Kawasaki, Hiromi Nakamura, Mihoko Saito-Adachi, Masami Suzuki, Erina Takai, Natsuko Hama, Ryota Higuchi, Seiko Hirono, Satoshi ShibaMamoru Kato, Chigusa Morizane, Koji Arihiro, Toru Furukawa, Laura D Wood, Ralph H Hruban, Tatsuhiro Shibata, et al.

Jejunocolic fistula presenting as chronic diarrhoea from advanced lymphoma. BMJ Case Report, 2022 Mar 3;15(3):e245495.

Velasco R, Ando M, Babaran HM, Manuntag MC, Sacdalan D

Cost-effectiveness analysis of endoscopic resection for colorectal laterally spreading tumors: Endoscopic submucosal dissection versus piecemeal endoscopic mucosal resection. Dig Endosc. 2022; 34: 553-68.

Sekiguchi M, Igarashi A, Mizuguchi Y, et al.

Burden of cancer attributable to modifiable factors in Japan in 2015

Manami Inoue, Mayo Hirabayashi, Sarah Krull Abe, Kota Katanoda, Norie Sawada, Yingsong Lin, Junko Ishihara, Ribeka Takachi, Chisato Nagata, Eiko Saito, Atsushi Goto, Kayo Ueda, Junko Tanaka, Megumi Hori, Tomohiro Matsuda, Cancer PAF Japan Collaborators

Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study

Anita Archwamety, Nattaya Teeyapun, Teerada Siripoon, Naravat Poungvarin, Suebpong Tanasanvimon, Ekaphop Sirachainan, Charuwan Akewanlop, Krittiya Korphaisarn

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer

Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Krittiya Korphaisarn, Nophol Leelayuwatanakul, Nopporn Pornpatrananrak, Naravat Poungvarin, Poonchavist Chantranuwat, Shanop Shuangshoti, Chatchawit Aporntewan, Wariya Chintanapakdee, Virote Sriuranpong, Chanida Vinayanuwattikun

Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial chemotherapy (GASPACHO study): a multicenter retrospective study. Jpn J Clin Oncol. 2022 Feb 5;52(2):134-142.

Yuta Maruki, et al.

Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review. Intern Med. 2022 Feb 19.

Yuta Maruki, et al.

Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. J Exp Clin Cancer Res. 2022 Feb 7;41(1):51.

Pei Jye Voon, et al.

Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy

Chikako Sekine, Nachiko Uchiyama, Chikashi Watase, Takeshi Murata, Sho Shiino, Kenjiro Jimbo, Eriko Iwamoto, Shin Takayama, Hiroaki Kurihara, Kaishi Satomi, Masayuki Yoshida, Takayuki Kinoshita, Akihiko Suto

Therapeutic targeting of DNA damage response in cancer, Int J Mol Sci. 2022 Feb1;23(3):1701

Wonyoung Choi, Eun Sook Lee

Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy

Kayo Nakata, Eiso Hiyama, Kota Katanoda, Tomohiro Matsuda, Yuma Tada, Masami Inoue, Keisei Kawa, Mitsue Maru, Chikako Shimizu, Keizo Horibe, Isao Miyashiro

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand. J Int AIDS Soc. 2022 Jan;25(1):e25862. doi: 10.1002/jia2.25862. PMID: 35001501; PMCID: PMC8743364.

Phongsamart W, Jantarabenjakul W, Chantaratin S, Anugulruengkitt S, Suntarattiwong P, Sirikutt P, Kosalaraksa P, Maleesatharn A, Chokephaibulkit K

Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution. Vaccines (Basel). 2022 Jan 13;10(1):118. doi: 10.3390/vaccines10010118. PMID: 35062779; PMCID: PMC8779595.

Rungmaitree S, Thepthai C, Toh ZQ, Musiwiraphat N, Maleesatharn A, Rermruay R, Sungkate S, Phongsamart W, Lapphra K, Wittawatmongkol O, Dharakul T, Mulholland K, Chokephaibulkit K

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent. Vaccines (Basel). 2022 Jan 17;10(1):134. doi: 10.3390/vaccines10010134. PMID: 35062795; PMCID: PMC8779427.

Kulsirichawaroj P, Sanmaneechai O, Wittawatmongkol O, Chokephaibulkit K

Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis

Sho Shiino, Graham Ball, Binafsha M Syed, Sasagu Kurozumi, Andrew R Green, Hitoshi Tsuda, Shin Takayama, Akihiko Suto, Emad A Rakha

Spectrum of cancer patients receiving renal biopsy

Fan-Chi Chang, Tom Wei-Wu Chen, Thomas Tao-Min Huang, Wei-Chou Lin, Jia-Sin Liu, Wen-Chih Chiang, Yung-Ming Chen, Chiun Hsu, Kun-Huei Yeh, Tzong-Shinn Chu

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors. Clin Cancer Res 28:95-105, 2022

Rottey S, Clarke J, Aung K, Machiels JP, Markman B, Heinhuis KM, Millward M, Lolkema M, Patel SP, de Souza P, Duca M, Curigliano G, Santoro A, Koyama T, Brown M, Vezina H, He C, Chu QS

Outcomes after mastectomy with immediate breast reconstruction for breast cancer in a multiethnic, middle-income Asian setting

Mee-Hoong See, Siamala Sinnadurai, Lee-Lee Lai, Keh-Ling Tan, Mei-Sze Teh, Li-Ying Teoh, Suniza Jamaris, Rozita Abdul Malik, Nirmala Bhoo-Pathy 6

Risk factors of Pancreatic Cancer in Vietnam: A Matched Case-Control Hospital-Based Study

Thuan Van Tran, Tu Van Dao, Khac-Dung Nguyen, To van Ta, Khanh Truong Vu, Son Hong Trinh, Hoang Cong Nguyen, Oanh Thi Bui, Quang Tien Nguyen, Hoan Duc Vu, Hiep Le Nguyen, Huong Thanh Tran

Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial.

Pei Jye Voon, et al.

Kinetic Changes of Peripheral Blood Monocyte Subsets and Expression of Co-Stimulatory Molecules during Acute Dengue Virus Infection. Pathogens. 2021 Nov 10;10(11):1458. doi: 10.3390/pathogens10111458. PMID: 34832614; PMCID: PMC8625762.

Lertjuthaporn S, Keawvichit R, Polsrila K, Sukapirom K, Chuansumrit A, Chokephaibulkit K, Ansari AA, Khowawisetsut L, Pattanapanyasat K

Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.

Shimoi T, Noguchi E, Sudo K, Chua YJ, Yonemori K

Delay in the diagnosis and treatment of breast cancer in Vietnam

Sang M Nguyen, Quang T Nguyen, Lan M Nguyen, Anh T Pham, Hung N Luu, Huong T T Tran, Thuan V Tran, Xiao-Ou Shu

Screening for Psychological Distress in Vietnamese Cancer Patients: An Evaluation of the Distress Thermometer

Tien Quang Nguyen, Tuyet Mai Do, Tuan Anh Pham

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers.

Shimoi T, Hashimoto J, Sudo K, Shimomura A, Noguchi E, Shimizu C, Yunokawa M, Yonemori K, Yoshida H, Yoshida M, Kato T, Kinoshita T, Fukuda T, Fujiwara Y, Tamura K

The clinical impact of capmatinib in the treatment of advanced non-small cell lung cancer with MET exon 14 skipping mutation or gene amplification, Cancer Res Treat. 2021 Oct;53(4):1024-1032

Wonyoung Choi, Seog-Yun Park, Youngjoo Lee, Kun Young Lim, Minjoung Park, Geon Kook Lee, Ji-Youn Han

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment. Medicine. 2020;99(38):e22331

Watanuki R, Shimomura A, Yazaki S, Noda-Narita S, Sumiyoshi-Okuma H, Nishikawa T, et al.

Moving from collective to distributed epidemiological cancer research

Tomohiro Matsuda

Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group study-post hoc analysis of JCOG1009/1010. Gastric Cancer. 2021 Sep;24(5):1123-1130.

Abe S, Takizawa K, Oda I, Mizusawa J, Kadota T, Ono H, Hasuike N, Yano T, Yamamoto Y, Horiuchi Y, Nagata S, Yoshikawa T, Terashima M, Muto M

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA). J Clin Oncol. 2021 Sep 2:JCO2100334. doi: 10.1200/JCO.21.00334

Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, et al.

Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer 2:962-977, 2021

Tanaka Y, Chiwaki F, Kojima S, Kawazu M, Komatsu M, Ueno T, Inoue S, Sekine S, Matsusaki K, Matsushita H, Boku N, Kanai Y, Yatabe Y, Sasaki H, Mano H

International strategy in cancer epidemiology: Japan’s involvement in global projects and future role

Tomohiro Matsuda, Keitaro Matsuo, Norie Sawada, Manami Inoue

Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer

Jeannie Hsiu Ding Wong, Zainor Zaili, Rozita Abdul Malik, Anita Zarina Bustam, Marniza Saad, Suniza Jamaris, Joanne Aisha Mosiun, Nur Aishah Mohd Taib, Ngie Min Ung, Mee-Hoong See

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan

Shu Yazaki, Tatsuya Yoshida, Yuki Kojima, Shigehiro Yagishita, Hiroko Nakahama, Keiji Okinaka, Hiromichi Matsushita, Mika Shiotsuka, Osamu Kobayashi, Satoshi Iwata, Yoshitaka Narita, Akihiro Ohba, Masamichi Takahashi, Satoru Iwasa, Kenya Kobayashi, Yuichiro Ohe, Tomokazu Yoshida, Akinobu Hamada, Toshihiko Doi, Noboru Yamamoto

Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children. Elife. 2021 Aug 3;10:e68917. doi: 10.7554/eLife.68917. PMID: 34342576; PMCID: PMC8382297.

Han AX, Felix Garza ZC, Welkers MR, Vigeveno RM, Tran ND, Le TQM, Pham Quang T, Dang DT, Tran TNA, Ha MT, Nguyen TH, Le QT, Le TH, Hoang TBN, Chokephaibulkit K, Puthavathana P, Nguyen VVC, Nghiem MN, Nguyen VK, Russell CA

An Alert to Possible False Positives With a Commercial Assay for MET Exon 14 Skipping. J Thorac Oncol 2021; 16: 2133-2138.

Teishikata T, Yatabe Y, et al.

Myxofibrosarcoma Harboring an MLH1 Pathogenic Germline Variant Associated with Muir-Torre Syndrome: A Case Report. Hered Cancer Clin Pract 19, no. 1 (Aug 21 2021): 34.

Nakagawa Makoto, Kobayashi Eisuke, Yamada Masayoshi, Watanabe Tomoko, Hirata Makoto, Tanabe Noriko, Ushiama Mineko, Sakamoto Hiromi, Sato Chiaki, Mori Taisuke, Yoshida Akihiko, Yoshida Teruhiko, Sugano Kokichi, Kawai Akira

Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer

Takeshi Murata, Chikashi Watase, Sho Shiino, Kenjiro Jimbo, Eriko Iwamoto, Masayuki Yoshida, Shin Takayama, Akihiko Suto

Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial

Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson, Hans Friedrich Koch, Subramanian Loganathan, Sarika Deodhar, Ashwani Marwah, Alexey Manikhas, Igor Bondarenko, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Sirshendu Roy, Eduardo Patricio Yanez Ruiz, Abhijit Barve, Cornelius F Waller

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer. NPJ Precis Oncol. 2021 Jul 16;5

Nakamura IT, Kohsaka S, et al.

Novel hybrid endoscopy-assisted larynx-preserving esophagectomy for cervical esophageal cancer (with video). Jpn J Clin Oncol. 2021 Jul 1;51(7):1171-1175. doi: 10.1093/jjco/hyab045.

Abe S, Oguma J, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Saito Y, Daiko H

Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes. Int J Tuberc Lung Dis. 2021 Jul 1;25(7):567-572. doi: 10.5588/ijtld.21.0060. PMID: 34183102.

Yangthara B, Wutthigate P, Roongmaitree S, Siripattanapipong P, Lapphra K, Kitsommart R, Phongsamart W, Ngerncham S, Wittawatmongkol O, Wongsiridach P, Chokephaibulkit K

Abstract 657: Folate receptor alpha expression is associated with poor prognosis in patients with cervical cancer. Cancer Research. 2021;81(13 Supplement):657-.

Takamizawa S, Yazaki S, Kojima Y, et al.

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study. Lancet Oncol. 2021 Jul;22(7):1034-1046.

Pujade-Lauraine E, Fujiwara K, Ledermann JA, Oza AM, Kristeleit R, Ray-Coquard IL, Richardson GE, Sessa C, Yonemori K, Banerjee S, Leary A, Tinker AV, Jung KH, Madry R, Park SY, Anderson CK, Zohren F, Stewart RA, Wei C, Dychter SS, et al.

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial. Lancet Child Adolesc Health. 2021 Sep;5(9):642-651. doi: 10.1016/S2352-4642(21)00165-6. Epub 2021 Jul 22. PMID: 34302760.

Gaur AH, Cotton MF, Rodriguez CA, McGrath EJ, Helström E, Liberty A, Natukunda E, Kosalaraksa P, Chokephaibulkit K, Maxwell H, Wong P, Porter D, Majeed S, Yue MS, Graham H, Martin H, Brainard DM, Pikora C

A novel combination of serum microRNAs for the detection of early gastric cancer. Gastric Cancer. 2021 Jul;24(4):835-843. doi: 10.1007/s10120-021-01161-0.

Abe S, Matsuzaki J, Sudo K, Oda I, Katai H, Kato K, Takizawa S, Sakamoto H, Takeshita F, Niida S, Saito Y, Ochiya T

Abstract 361: Mesothelin expression varies by histological type in patients with cervical cancer and is reduced in metastatic tumors. Cancer Research. 2021;81(13 Supplement):361

Yazaki S, Kojima Y, Yoshida H, et al.

First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors. Clin Cancer Res. 2021 Jul 15;27(14):3905-3915.

Shimizu T, Fujiwara Y, Yonemori K, Koyama T, Sato J, Tamura K, Shimomura A, Ikezawa H, Nomoto M, Furuuchi K, Nakajima R, Miura T, Yamamoto N

Visualization of intra-tumor pharmacokinetics of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2 heterogeneous model using phosphor-integrated dots imaging analysis. Clin Cancer Res. 2021:clincanres.0397.2021

Suzuki M, Yagishita S, Sugihara K, Ogitani Y, Nishikawa T, Ohuchi M, et al.

Potent Anti-tumor Effect of T cells armed with Anti-GD2 Bispecific Antibody. Pediatr Blood Cancer 2021;68(7)

Nakajima M, Guo H, Hoseini S, Xu H, Cheung NK

Comprehensive molecular profiling of pulmonary pleomorphic carcinoma. NPJ Precis Oncol. 2021 Jun 22;5

Nagano M, Kohsaka S, Hayashi T, Ueno T, Kojima S, Shinozaki-Ushiku A, Morita S, Tsuda M, Tanaka S, Shinohara T, Omori Y, Sugaya F, Kato H, Narita Y, Nakajima J, Suzuki K, Takamochi K, Mano H

Role of Immunotherapy in Pulmonary Angiosarcoma: A Case Report

Quang Tien Nguyen, Anh Tuan Pham, Thuy Thi Nguyen, Tam Thi Thanh Nguyen, Ky Van Le

Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy. Virchows Archiv : an international journal of pathology. 2021.

Yoshida H, Nishikawa T, Matsumoto K, Mori M, Hirashima Y, Takehara K, et al.

Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy. Virchows Arch. 2021 Jun;478(6):1161-1171.

Yoshida H, Nishikawa T, Matsumoto K, Mori M, Hirashima Y, Takehara K, Ariyoshi K, Hasegawa K, Yonemori K

Endoscopic ultrasound-guided choledochoduodenostomy without fistula dilation using a novel fully covered metallic stent with a 5.9-Fr ultra-thin delivery system. Endoscopy. 2021 Jun;53(6):E223-E225.

Yuta Maruki, et al.

Exploration of Patient-Related Barriers to Effective Cancer Pain Management in a Diverse Multicultural Developing Country. J Pain Symptom Manage. 2020 Nov 14:S0885-3924(20)30876-9.

Kiu DKL, Lee ZFD, Pei Jye Voon

The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.

Kawauchi D, Takahashi M, Satomi K, Yamamuro S, Kobayashi T, Uchida E, et al.

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson, Hans Friedrich Koch, Subramanian Loganathan, Sarika Deodhar, Ashwani Marwah, Alexey Manikhas, Igor Bondarenko, Guzel Mukhametshina, Gia Nemsadze, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Kakhaber Baramidze, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Cornelius F Waller, et al.

Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT

Takuji Okusaka, Kenji Ikeda, Masatoshi Kudo, Richard Finn, Shukui Qin, Kwang-Hyub Han, Ann-Lii Cheng, Fabio Piscaglia, Masahiro Kobayashi, Max Sung, Minshan Chen, Lucjan Wyrwicz, Jung-Hwan Yoon, Zhenggang Ren, Kalgi Mody, Corina Dutcus, Toshiyuki Tamai, Min Ren, Seiichi Hayato, Hiromitsu Kumada

A Pilot Study of Synchronization of Respiration-Induced Motions in the Duodenum and Stomach for the Primary Tumor in Radiation Therapy for Pancreatic Cancer Using 4-Dimensional Computed Tomography. Adv Radiat Oncol. 2021 May 27;6(4):100730. doi: 10.1016/j.adro.2021.100730.

Umezawa R, Wakita A, Katsuta Y, Ito Y, Nakamura S, Okamoto H, Kadoya N, Takahashi K, Inaba K, Murakami N, Igaki H, Jingu K, Itami J

Real World Experience of Long Term Treatment Outcome in Hormone Receptor-positive Metastatic Breast Cancer with or without Everolimus and Exemestane after Prior Aromatase Inhibitor.

Dajsakdipon T, Konmun J, Udomsubpayakul U, Dejthevaporn T

Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer. Jpn J Clin Oncol. 2021;51(3):321-332.

Noguchi E, Shien T, Iwata H

Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single-cell level. Cancer Sci. 2021 May;112(5):2006-2019.

Nakamura IT, Ikegami M, Hasegawa N, Hayashi T, Ueno T, Kawazu M, Yagishita S, Goto Y, Shinno Y, Kojima Y, Takamochi K, Takahashi F, Takahashi K, Mano H, Kohsaka S

Regulatory and Operational Challenges in Conducting Asian International Academic Trial for Expanding the Indications of Cancer Drugs. Clin Transl Sci. 2021;14:1015-1025.

Hata T, Nakamura K, Yonemori K, Noguchi E, Watanabe M, Sohn J, Lu YS, Yap YS, Tamura K, Fuiwara Y

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B). Breast cancer. 2021;28(3):581-91.

Yokoe T, Kurozumi S, Nozawa K, Ozaki Y, Maeda T, Yazaki S, et al.

Comprehensive molecular and clinicopathological profiling of desmoid tumors. European Journal of Cancer. 145, 109-120, 2021.

Kohsaka S, Hirata M, Ikegami M, Ueno T, Kojima S, Sakai T, Ito K, Naka N, Ogura K, Kawai A, Iwata S, Okuma T, Yonemoto T, Kobayashi H, Suehara Y, Hiraga H, Kawamoto T, Motoi T, Oda Y, Mano H, et al.

Extensive functional evaluation of exon 20 insertion mutations of EGFR. Lung Cancer. 152, 135-142, 2021.

Hirose T, Ikegami M, Endo M, Matsumoto Y, Nakashima Y, Mano H, Kohsaka S

HRQOL Assessment for Solid Tumor Patients on Immuno-Oncology Therapies. Cancer. 2021 Mar 4

Pei Jye Voon, David Cella, Aaron R Hansen

Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study. Pathogens. 2021 May 19;10(5):625. doi: 10.3390/pathogens10050625. PMID: 34069574; PMCID: PMC8161181

Techasaensiri C, Wongsa A, Puthanakit T, Chokephaibulkit K, Chotpitayasunondh T, Charoonruangrit U, Sombatnimitsakul S, Puthavathana P, Lerdsamran H, Auewarakul P, Tassaneetrithep B

Cholangiocarcinoma: is it time for a revolution?

Takuji Okusaka

Laparoscopic surgery using 8K ultra-high definition technology: Outcomes of a phase II study. Asian J Endosc Surg 2021 April; 21

Shunsuke Tsukamoto, Aya Kuchiba, Konosuke Moritani, Dai Shida, Hiroshi Katayama, Eiko Yorikane, Yukihide Kanemitsu

Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target. Sci Rep. 2021 Apr 13;11(1):8090. doi: 10.1038/s41598-021-87627-8.

Nakamura S, Igaki H, Ito M, Imamichi S, Kashihara T, Okamoto H, Nishioka S, Iijima K, Chiba T, Nakayama H, Takemori M, Abe Y, Kaneda T, Takahashi K, Inaba K, Okuma K, Murakami N, Nakayama Y, Masutani M, Nishio T, et al.

A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning. Biomolecules.

Takahashi S, Takahashi M, Tanaka S, Takayanagi S, Takami H, Yamazawa E, et al.

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun

Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast Cancer. Oncologist. 2021;26(4):e686-e693.

Sagara Y, Mori M, Yamamoto S, Eguchi K, Iwatani T, Naito Y, Kogawa T, Tanaka K, Kotani H, Yasojima H, Ozaki Y, Noguchi E, Miyasita M, Kondo N, Niikura N, Toi M, Shien T, Iwata H

First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors. Cancer Sci. 2021 Apr;112(4):1514-1523.

Kondo S, Shimizu T, Koyama T, Sato J, Iwasa S, Yonemori K, Fujiwara Y, Shimomura A, Kitano S, Tamura K, Yamamoto N

The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study. Jpn J Clin Oncol. 2021 Apr 30;51(5):693-699.

Yonemori K, Shimizu T, Kondo S, Iwasa S, Koyama T, Kitano S, Sato J, Shimomura A, Shibaki R, Suri A, Kase Y, Sumino S, Tamura K, Yamamoto N

Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma. Mod Pathol.

Satomi K, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Narita Y, et al.

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.

Kitadai R, Shimoi T, Sudo K, Noguchi E, Nagata Y, Sawada R, Takashima A, Boku N, Yonemori K

Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among Facilities. Cancers (Basel).

Takahashi S, Takahashi M, Kinoshita M, Miyake M, Kawaguchi R, Shinojima N, et al.

Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors. JCO Precision Oncology. 2021(5):756-66.

Takeyasu Y, Okuma HS, Kojima Y, Nishikawa T, Tanioka M, Sudo K, Tatsunori Shimoi , Emi Noguchi, Ayumu Arakawa, Taisuke Mori, Kuniko Sunami, Takashi Kubo, Takashi Kohno, Yoshida Akihiko, Noboru Yamamoto, Kan Yonemori, et al.

Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis. Gastric Cancer. 2021 Mar;24(2):283-291.

Cho Hourin, Yamada Masayoshi, Sekine Shigeki, Tanabe Noriko, Ushiama Mineko, Hirata Makoto, Ogawa Gakuto, Gotoh Masahiro, Yoshida Teruhiko, Yoshikawa Takaki, Saito Yutaka, Kuchiba Aya, Oda Ichiro, Sugano Kokichi

Treatment outcome and prognosis factors of FIGO 2018 stage III cervical cancer patients treated with definitive concurrent chemoradiation in Vietnam. Asian Pacific Journal of Cancer Prevention. 2021. doi: 10.31557/APJCP.2021.22.3.853

Phung Thi Huyen, Nguyen Thi Hoa, et al.

Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan. JCO Oncol Pract. 2021;17(3):e416-e425.

Bun S, Yonemori K, Sunadoi H, Nishigaki R, Noguchi E, Okusaka T, Nishida T, Fujiwara Y

ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. Am J Surg Pathol. 2021 Mar 1;45(3):347-355.

Kashima J, Yoshida M, Jimbo K, Izutsu K, Ushiku T, Yonemori K, Yoshida A

Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan. JCO Oncol Pract. 2021 Mar;17(3):e416-e425

Bun S, Yonemori K, Sunadoi H, Nishigaki R, Noguchi E, Okusaka T, Nishida T, Fujiwara Y

Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study). J Gastroenterol. 2021 Mar;56(3):250-260.

Yuta Maruki, Chigusa Morizane, Yasuhito Arai, Masafumi Ikeda, Makoto Ueno, Tatsuya Ioka, Atsushi Naganuma, Masayuki Furukawa, Nobumasa Mizuno, Tadashi Uwagawa, Naminatsu Takahara, Masashi Kanai, Akinori Asagi, Satoshi Shimizu, Atsushi Miyamoto, Seigo Yukisawa, Makoto Kadokura, Yasushi Kojima, Junji Furuse, Takako Eguchi Nakajima, et al.

Disclosure of HIV status to sexual partners among perinatally HIV-infected youth in Thailand. Int J STD AIDS. 2021 Mar;32(4):361-367. doi: 10.1177/0956462420968405. Epub 2021 Feb 11. PMID: 33571066.

Boon-Yasidhi V, Torsakul S, Durier Y, Sittanomai N, Kuntasorn J, Chokephaibulkit K

Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives

Chikashi Watase, Sho Shiino, Tatsunori Shimoi, Emi Noguchi, Tomoya Kaneda, Yusuke Yamamoto, Kan Yonemori, Shin Takayama, Akihiko Suto

Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup. Clin Transl Gastroenterol. 20212021; 12: e00319.

Sekiguchi M, Kakugawa Y, Ikematsu H, et al.

Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

Fabio Augusto Barros Schutz, Ekaphop Sirachainan, Shanggar Kuppusamy, Nguyen Thi Thai Hoa, Thitiya Dejthevaporn, Badrulhisham Bahadzor, Vu Quang Toan, Phichai Chansriwong, Adlinda Alip, Nguyen Thi Minh Hue, Napa Parinyanitikul, Ai Lian Tan, Vu Dinh Khanh Hoang, Piyawan Tienchaiananda, Sai Naga Deepak Chinchapattanam, Amit Garg

Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital

Vitcha Poonyakanok, Prasong Tanmahasamut, Atthapon Jaishuen, Thanyarat Wongwananuruk, Chutimon Asumpinwong, Nalinee Panichyawat, Panicha Chantrapanichkul

Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants. N Engl J Med. 2021;384(1):42-50.

Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, Yonemori K, Noguchi E, Sunami K, Shiraishi K, Kakishima H, Yoshida H, Hishiki T, Kawakubo N, Kuroda T, Kiyokawa T, Yamada K, Yanaihara N, Takahashi K, Okamoto A, et al.

The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium

Tom Wei-Wu Chen, Angela Pang, Mark E Puhaindran, Myo Myint Maw, Herbert H Loong, Virote Sriuranpong, Chih-Chi Chang, Siyamol Mingmalairak, Takeshi Hirose, Makoto Endo, Akira Kawai, Mohamad Farid, Sze Huey Tan, Wei Lin Goh, Richard Quek, Jeffrey C H Chan, Alex K C Leung, Roger K C Ngan

The journey to develop the ideal submucosal injection solution for endoscopic submucosal dissection. Gastrointest Endosc. 2021 Feb;93(2):514-516.

Abe S, Bhatt A, Saito Y

Drain Placement After Uncomplicated Hepatic Resection Increases Severe Postoperative Complication Rate A Japanese Multi-institutional Randomized Controlled Trial (ND-trial) Ann Surg. 2021 Feb 1;273(2):224-231

Arita, Junichi, Shimada, Kazuaki, et al.

Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients

Rattanawadee Teocharoen, Komkrit Ruangritchankul, Chanida Vinayanuwattikun, Virote Sriuranpong, Piyada Sitthideatphaiboon

Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.

Kasumi Yamamoto, Shoji Nagao, Tomoharu Tsu, Taeko Matsushima, Yoshimi Ishido, Moyu Narita, Kazuhiro Suzuki, Hiroshi Nakazawa, Takashi Shibutani, Tomoatsu Jimi, Hiroko Yano, Miho Kitai, Takaya Shiozaki, Kazuko Matsuoka, Satoshi Yamaguchi

Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants. N Engl J Med.2021; 384 (1): 42-50

Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, et al.

Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Thi Oanh Bui, Van Tu Dao, Van Tai Nguyen, Jean-Paul Feugeas, Frédéric Pamoukdjian, Guilhem Bousquet

A case of lymph node dissection for contralateral axillary lymph node metastasis of ipsilateral breast tumor recurrence after identifying the primary lymphatic drainage by lymphoscintigraphy

Haruhi Maseki, Shin Takayama, Masayuki Yoshida, Uta Nakadaira, Chikashi Watase, Sho Shiino, Takeshi Murata, Kenjiro Jimbo, Akihiko Suto

A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis, J Cancer Res Clin Oncol. 2021 Jan;147(1):213-222

Wonyoung Choi, Youngnam Cho, Seog-Yun Park, Kum Hui Hwang, Ji-Youn Han, Youngjoo Lee

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer. Oncol Lett. 2020 Dec;20(6):336.

Mizuno T, Kojima Y, Yonemori K, Yoshida H, Sugiura Y, Ohtake Y, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Shimomura A, Noguchi E, Kato T, Shimoi T, Uno M, Ishikawa M, Fujiwara Y, Ohe Y, Tamura K

Aggressive lactating adenoma mimicking breast carcinoma: A case report.” International Journal of Surgery Case Reports. 2020. https://doi.org/10.1016/j.ijscr.2020.03.047.

Phung Thi Huyen, Nguyen Thi Hoa, et al.

Hans-Henning Flechtner Andrew Bottomley on behalf of the EORTC Quality of Life and Gastro-intestinal Groups. Minimally important differences for interpreting the EORTC QLQ-C30 in advanced colorectal cancer patients treated with chemotherapy. 2020 Dec;22(12):2278-2287. doi: 10.1111/codi.15295.

Jammbe Z Musoro, Sodergren C Samantha, Corneel Coens, Alessia Pochesci, Mitsumi Terada, Madeleine T King, Mirjam AG Sprangers, Mogens Groenvold, Kim Cocks, Galina Velikova

Reaccesssing molecular subtype of SCLC. J Thorac Oncol (Editorial) 2020; 15: 1819-1822.

Yasushi Yatabe

Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam

Tu Van Dao, Chu Van Nguyen, Quang Tien Nguyen, Ha Thi Ngoc Vu, Huyen Thi Phung, Oanh Thi Bui, Dung Khac Nguyen, Bang Viet Luong, Thuan Van Tran

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies

Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Kentaro Yamazaki, Akihito Tsuji, Wataru Okamoto, Katsuya Tsuchihara, Takeharu Yamanaka, Izumi Miki, Yasutoshi Sakamoto, Hiroko Ichiki, Masayuki Hata, Riu Yamashita, Atsushi Ohtsu, Justin I Odegaard, Takayuki Yoshino, et al.

Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan.

Deguchi S, Nakasu Y, Sakaida T, Akimoto J, Tanahashi K, Natsume A, Takahashi M, et al.

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Mrinal Gounder, Patrick Schöffski, Robin L Jones, Mark Agulnik, Gregory M Cote, Victor M Villalobos, Steven Attia, Rashmi Chugh, Tom Wei-Wu Chen, Thierry Jahan, Elizabeth T Loggers, Abha GuptaAntoine Italiano, George D Demetri, Ravin Ratan, Lara E Davis, Olivier Mir, Palma Dileo, Brian A Van Tine, Shefali Agarwal, Silvia Stacchiotti , et al.

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer

Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, Huu-Vinh Vu, Shun Lu, Kye-Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Lingmin Zeng, et al.

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam”. Breast Cancer: Targets and Therapy. 2020. https://doi.org/10.2147/BCTT.S268369.

Phung Thi Huyen, Nguyen Thi Hoa, et al.

Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective study. Anti-cancer drugs. 2020;31(9):973-8.

Yazaki S, Hashimoto J, Ogita S, Nakano E, Suzuki K, Yamauchi T

Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer. Jpn J Clin Oncol. 2020 Oct 22;50(11):1333-1341. doi: 10.1093/jjco/hyaa119.

Mitsumi Terada, Kenichi Nakamura, Francesca Martinelli, Madeline Pe, Junki Mizusawa, Junko Eba, Haruhiko Fukuda, Naomi Kiyota, Laureline Gatellier, Yoshiyuki Majima, Galina Velikova, Andrew Bottomley

Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR.

Miki S, Satomi K, Ohno M, Matsushita Y, Kitahara M, Miyakita Y, Masamichi Takahashi, et al.

Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)

Naohiro Okano, Chigusa Morizane, Shogo Nomura, Hideaki Takahashi, Hidetaka Tsumura, Hironaga Satake, Nobumasa Mizuno, Kunihiro Tsuji, Kazuhiko Shioji, Akinori Asagi, Kohichiroh Yasui, Sho Kitagawa, Tomomi Kashiwada, Atsushi Ishiguro, Masashi Kanai, Makoto Ueno, Takashi Ogura, Satoshi Shimizu, Takuji Okusaka, Junji Furuse

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment. Medicine (Baltimore). 2020;99(38):e22331.

Watanuki R, Shimomura A, Yazaki S, Noda-Narita S, Sumiyoshi-Okuma H, Nishikawa T, et al.

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.

Shoji Nagao, Kasumi Yamamoto, Tetsuro Oishi, Satoshi Yamaguchi, Kazuhiro Takehara, Muneaki Shimada, Junzo Kigawa

A novel endoscopic hand-suturing technique for defect closure after colorectal endoscopic submucosal dissection: a pilot study. Endoscopy. 2020 Sep;52(9):780-785.

Abe S, Saito Y, Tanaka Y, Ego M, Yanagisawa F, Kawashima K, Takamaru H, Sekiguchi M, Yamada M, Sakamoto T, Matsuda T, Goto O, Yahagi N

MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial. Clin Pharmacol Ther. 2020 Sep;108(3):596-605.

Okuma HS, Yonemori K, Narita SN, Sukigara T, Hirakawa A, Shimizu T, Shibata T, Kawai A, Yamamoto N, Nakamura K, Nishida T, Fujiwara Y

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging. Sci Rep. 2020 Sep 23;10(1):15535.

Ryu S, Ohuchi M, Yagishita S, Shimoi T, Yonemori K, Tamura K, Fujiwara Y, Hamada A

Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video). Gastrointest Endosc. 2020 Sep.

Yuta Maruki, et al.

Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis-associated Traditional Serrated Adenoma. Am J Surg Pathol 44:1282-1289 (2020)

Okamura Takuma, Hashimoto Taiki, Naka Tomoaki, Yoshida Teruhiko, Tanabe Noriko, Ogawa Reiko, Yamada Masayoshi, Saito Yutaka, Yatabe Yasushi, Sekine Shigeki

Collision tumour of endometrial stromal sarcoma, uterine tumour resembling ovarian sex-cord tumour, and leiomyoma.

Chiharu Mizoguchi, Harunobu Matsumoto, Kaei Nasu, Kentaro Kai, Motoki Arakane, Hisashi Narahara

Neoadjuvant Cisplatin in BRCA Carriers With HER2-Negative Breast Cancer.

Takamizawa S, Ishiki H, Shimoi T, Shimizu M, Satomi E

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020 Aug 20;182(4):1044-1061.e18

Hoshino A, Han Sang K, Nakajima M, et al.

What is the value of health-related quality of life in a negative superiority trial? Ann Oncol 2020; 31: 976-977.

Nakamura K, Maruyama D

Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia

Tomohiro Matsuda, Young-Joo Won, RuRu Chun-Ju Chiang, Jiwon Lim, Kumiko Saika, Keisuke Fukui, Wen-Chung Lee, Laura Botta, Alice Bernasconi, Annalisa Trama

Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis, Taget Oncol. 2020 Aug;15(4):513-522

Wonyoung Choi, Hyun-Ju Lim, Seog-Yun Park, Ji-Youn Han, Heung Tae Kim, Jin Soo Lee, Youngjoo Lee

Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 Aug 1;26(15):4072-4079.

Alissa J Cooper, Yoshihisa Kobayashi, Dewey Kim, Sarah E Clifford, Sasha Kravets, Suzanne E Dahlberg, Emily S Chambers, Jiaqi Li, Deepa Rangachari, Tom Nguyen, Daniel B Costa, Michael S Rabin, Nikhil Wagle, Lynette M Sholl, Pasi A Jänne, Geoffrey R Oxnard

Cancer registration in China and its role in cancer prevention and control

Wenqiang Wei, Hongmei Zeng, Rongshou Zheng, Siwei Zhang, Lan An, Ru Chen, Shaoming Wang, Kexin Sun, Tomohiro Matsuda, Freddie Bray, Jie He

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)V600E Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis. JMA J. 2020 Jul 15;3(3):274-279. doi: 10.31662/jmaj.2020-0016. Epub 2020 Jul 7.

Yokomichi H, Inozume T, Wada M, Asai J, Igaki H, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Koga H, Nakamura Y, Mochizuki M, Yamagata Z

Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.

Tanaka S, Sato I, Takahashi M, Armstrong TS, Cleeland CS, Mendoza TR, et al.

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

Jasmine Lim, Akara Amantakul, Nisha Shariff, Bannakij Lojanapiwat, Adlinda Alip, Teng Aik Ong, Shankaran Thevarajah, Firdaus Ahmayuddin, Adeline Mathew, Supon Sriplakich, Jaraspong Vuthiwong, Flora Li Tze Chong, Marniza Saad

Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Chee-Shee Chai, Chong-Kin Liam, Mau-Ern Poh, Diana Bee-Lan Ong, Yong-Kek Pang, Phaik-Leng Cheah, Gwo-Fuang Ho, Adlinda Alip

High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan. Int J Clin Oncol. 2020;25(7):1327-1333.

Yazaki S, Yamauchi T, Higashi T

Identification of novel CD74-NRG2α fusion from comprehensive profiling of lung adenocarcinoma in Japanese never or light smokers. Journal of Thoracic Oncology. 2020 Jun, 15 (6), 948-961.

Kohsaka S, Hayashi T, Nagano M, Ueno T, Kojima S, Kawazu M, Shiraishi Y, Kishikawa S, Suehara Y, Takahashi F, Takahashi K, Suzuki K, Takamochi K, Mano H

Changing the Landscape of Medical Oncology Training at the National University Hospital in the Philippines during the Coronavirus Disease 2019 (COVID-19) Pandemic. Journal of Cancer Education, 2020 Jun 5;1-3..

Alfredo Chua Jr, Marvin Jonne Mendoza, Mark Ando, Cyril Jonas Planilla, Gracieux Fernando, Heinrik Martin Jude Strebel, Jorge Ignacio

Combination of 1.1 mm flexible cryoprobe with conventional guide sheath and therapeutic bronchoscope in biopsy of apical upper lobe solitary pulmonary nodule

Sze Shyang Kho, Chan Sin Chai, Larry Ellee Nyanti, Adam Malik Bin Ismail, Siew Teck Tie

Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer

P Sitthideatphaiboon, S Santisukwongchote, S Khunsri, C Sathitruangsak, P Chantranuwat, C Vinayanuwattikun, V Sriuranpong

Family history of colorectal cancer and prevalence of advanced colorectal neoplasia in asymptomatic screened populations in different age groups. Gastrointest Endosc. 2020; 91: 1361-70.

Sekiguchi M, Kakugawa Y, Nakamura K, et al.

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Toyama T

High-Throughput Functional Evaluation of BRCA2 Variants of Unknown Significance. Nature Communications. 11, 2573, 2020.

Ikegami M, Kohsaka S, et al.

Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.

Miyakita Y, Ohno M, Takahashi M, Kurihara H, Katai H, Narita Y

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer

Tu Dao, Guillaume Gapihan, Christophe Leboeuf, Diaddin Hamdan, Jean-Paul Feugeas, Hanene Boudabous, Laurent Zelek, Catherine Miquel, Thuan Tran, Catherine Monnot, Stéphane Germain, Anne Janin, Guilhem Bousquet

Comparison of 18FBPA uptake with 18FDG uptake in cancer patients. Appl Radiat Isot. 2020 Mar;157:109019. doi: 10.1016/j.apradiso.2019.109019. Epub 2019 Dec 7.

Igaki H, Nakamura S, Kurihara H, Abe Y, Nishioka S, Fujii R, Nakamura M, Nakayama Y, Morita T, Okamoto H, Imahori Y, Itami J

High-throughput functional evaluation of BRCA2 variants of unknown significance. Nat Commun 11:2573, 2020

Ikegami M, Kohsaka S, Ueno T, Momozawa Y, Inoue S, Tamura K, Shimomura A, Hosoya N, Kobayashi H, Tanaka S, Mano H

An Asian Body to Tackle Cancers in Asia – The Asian National Cancer Centers Alliance

Laureline Gatellier, Tomohiro Matsuda, Kanaga Sabapathy, Min Dai, Luh Komang Mela Dewi, Tran Thanh Huong, Kardinah Kardinah, Tran Van Thuan, Jong Bae Park, Jie He, Erdenekhuu Nansalmaa, Bayarsaikhan Luvsandorj, William Ying Khee Hwang, Manju Sengar, C S Pramesh, Tatsuya Suzuki

Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis

Takuji Okusaka, Masafumi Nakamura, Masahiro Yoshida, Masayuki Kitano, Katsuhiko Uesaka, Yoshinori Ito, Junji Furuse, Keiji Hanada, Kazuichi Okazaki, Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society

Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival

Tom Wei-Wu Chen, I-Shiow Jan, Dwang-Ying Chang, Ching-Hung Lin, I-Chun Chen, Ho-Min Chen, Ann-Lii Cheng, Yen-Shen Lu

Regulatory changes after the enforcement of the new Clinical Trials Act in Japan. Jpn J Clin Oncol 2020; 50: 399-404.

Nakamura K, Shibata T

Long-term follow up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). BJS. 2020; 107: 586-594

S Tsukamoto, S Fujita, M Ota, J Mizusawa, D Shida, Y Kanemitsu, M Ito, A Shiomi, K Komori, M Ohue, Y Akazai, M Shiozawa, T Yamaguchi, H Bando, A Tsuchida, S Okamura, Y Akagi, N Takiguchi, Y Saida, T Akasu, et al.

Impact of Obesity on Outcomes of Operable Breast Cancer: A Retrospective Cohort Study

Tanapat Engkakul, Nuntakorn Thnogtang, Akarin Nimmannit, Suebwong Chuthapisith, Charuwan Akewanlop

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

Takuji Okusaka, Junji Furuse

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation. Case Rep Oncol Med. 2020;2020:2518383

Seo T, Noguchi E, Yoshida M, Mori T, Tanioka M, Sudo K, Shimomura A, Yonemori K, Fujiwara Y, Tamura K

Clinical research in cancer palliative care: a metaresearch analysis. BMJ Support Palliat Care. 2020 Jun;10(2):249-258. doi: 10.1136/bmjspcare-2019-002086. Epub 2020 Mar 24.

Vinches M, Neven A, Fenwarth L, Terada M, Rossi G, Kelly S, Peron J, Thomaso M, Grønvold M, De Rojas T

Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report

Sho Shiino, Masayuki Yoshida, Momoko Tokura, Chikashi Watase, Takeshi Murata, Kenjiro Jimbo, Shin Takayama, Akihiko Suto, Kaishi Satomi, Akiko Miyagi Maeshima, Mari Kikuchi, Nachiko Uchiyama, Takayuki Kinoshita

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

K Park, J Vansteenkiste, K H Lee, G Pentheroudakis, C Zhou, K Prabhash, T Seto, P J Voon, D S W Tan, J C H Yang, J Wang, K Govind Babu, Y Nakayama, A Alip, K L M Chua, J C-H Cheng, S Senan, Y C Ahn, T Yoshino, J-Y Douillard, et al.

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. J Dermatol. 2020 Feb;47(2):89-103. doi: 10.1111/1346-8138.15151. Epub 2019 Nov 28.

Nakamura Y, Asai J, Igaki H, Inozume T, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Ito T, Imafuku K, Tanaka R, Teramoto Y, Minagawa A, Miyagawa T, Miyashita A, Wada M, Koga H, Sugaya M

Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab. Japanese journal of clinical oncology. 2020;50 (2), 114-121.

K Sudo, K Kato, J Matsuzaki, S Takizawa, Y Aoki, H Shoji, S Iwasa, Y Honma, A Tma, H Sakamoto, T Naka, S Sekine, N Boku, T Ochiya

Locally advanced triple negative breast cancer arising fromfibroadenoma with complete response to neoadjuvant chemotherapy:A case report. International Journal of Surgery Case Reports. 2020:68:234-238

Sho Shiino, Masayuki Yoshida, Momoko Tokura, Chikashi Watase, Takeshi Murata, Kenjiro Jimbo, Shin Takayama, Akihiko Suto, Kaishi Satomi, Akiko Miyagi Maeshima, Mari Kikuchi, Nachiko Uchiyama, Takayuki Kinoshita

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors

Jih-Hsiang Lee, Tom Wei-Wu Chen, Chih-Hung Hsu, Yu-Hsin Yen, James Chih-Hsin Yang, Ann-Lii Cheng, Shun-Ichi Sasaki, LiYin Lillian Chiu, Masahiro Sugihara, Tomoko Ishizuka, Toshihiro Oguma, Naoyuki Tajima, Chia-Chi Lin

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, Tom Wei-Wu Chen, Cheng-Ming Sun, Julien Calderaro, Yung-Ming Jeng, Li-Ping Hsiao, Laetitia Lacroix, Antoine Bougoüin, Marco Moreira, Guillaume Lacroix, Ivo Natario, Julien Adam, Carlo Lucchesi, Yec Han Laizet, Maud Toulmonde, Melissa A Burgess, Vanessa Bolejack, Catherine Sautès-Fridman , et al.

First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors. Cancer Sci 111:571-579, 2020

Koyama T, Shimizu T, Iwasa S, Fujiwara Y, Kondo S, Kitano S, Yonemori K, Shimomura A, Iizumi S, Sasaki T, Furuse J, Yamamoto N

Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during 60 Co HDR CT-based intracavitary cervix brachytherapy

Z Jamalludin, W L Jong, R A Malik, A B Rosenfeld, N M Ung

Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology. 2020;98(10):699-705.

Ebata T, Yonemori K, Nishikawa T, Sudo K, Shimomura A, Noguchi E, et al.

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer. 2020;126(1):98-104.

Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, et al.

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. Eur J Cancer. 2020 Jan;124:67-76. doi: 10.1016/j.ejca.2019.09.006. Epub 2019 Nov 20.

Wagner AD, Lordick F, Grabsch HI, Terashima M, Terada M, Yoshikawa T, Boku N, Kataoka K, Smyth EC, Mauer M, Haustermans K, Moehler MH

Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial, Cancer Res Treat. 2020 Jan;52(1):246-253

Wonyoung Choi, Jong Gwang Kim, Seung-Hoon Beom, Jun-Eul Hwang, Hyun-Jung Shim, Sang-Hee Cho, Min-Ho Shin, Sin-Ho Jung, Ik-Joo Chung, Joon Young Song, Woo Kyun Bae

A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study). Jpn J Clin Oncol. 2019 Dec 27;49(12):1172-1175. doi: 10.1093/jjco/hyz169.

Kadota T, Saito R, Kumabe T, Mizusawa J, Katayama H, Sumi M, Igaki H, Kinoshita M, Komori T, Ichimura K, Narita Y, Nishikawa R

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.

Somkiat Sunpaweravong, Sacarin Bunbanjerdsuk, Tanjitti Pongrujikorn, Chaiwat Naktang, Patrapim Sunpaweravong, Anupong Nitiruangjaras, Tanadech Dechaphankul, Natini Jinawath

Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE). Jpn J Clin Oncol. 2019 Dec 18;49(11):1055-1060. doi: 10.1093/jjco/hyz112

Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y

Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.

Ohno M, Matsuzaki J, Kawauchi J, Aoki Y, Miura J, Takizawa S, Takahashi M, et al.

Recommendations for promoting international multi-site clinical trials-from a viewpoint of ethics review. Dev World Bioeth 2019; 19: 192-195.

Nakada H, Hasthorpe S, C IJ, Kombe F, Ba M, Matei M, Nakamura K, Ushirozawa N, Fujiwara Y, Tashiro S

Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer

T Quang Nguyen, T Oanh Bui, P Thao Tran, V Thuan Tran, V Hieu Nguyen, Q Hoan Chu, T A Tuyet Bui, N Quynh Le, V Quang Le, V Tu Dao

Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome

Chanida Vinayanuwattikun, Ornjira Prakhongcheep, Sucharat Tungsukruthai, Korrakod Petsri, Prapassorn Thirasastr, Nophol Leelayuwatanakul, Pithi Chanvorachote

Internet Survey of Clinical Trial Information for Patients at University Hospitals in Japan

Sasaki T, Sambe T, Yamazaki T, Uchikura T, Takenoshita S, Ryu K, Hida N, Uchida N, Kobayashi S

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

C Morizane, T Okusaka, J Mizusawa, H Katayama, M Ueno, M Ikeda, M Ozaka, N Okano, K Sugimori, A Fukutomi, H Hara, N Mizuno, H Yanagimoto, K Wada, K Tobimatsu, K Yane, S Nakamori, H Yamaguchi, Y Kojima, K Nakamura, et al.

Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience

Titaporn Nopmaneepaisarn, Napadon Tangjaturonrasme, Worawat Rawangban, Chanida Vinayanuwattikun, Somboon Keelawat, Andrey Bychkov

Germline mutations in cancer-predisposition genes in patients with biliary tract cancer

Takeshi Terashima, Kumiko Umemoto, Hideaki Takahashi, Hiroko Hosoi, Erina Takai, Shunsuke Kondo, Yasunari Sakamoto, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Mitsuhito Sasaki, Masafumi Ikeda, Kazuaki Shimada, Shuichi Kaneko, Shinichi Yachida, Kokichi Sugano, Takuji Okusaka, Chigusa Morizane

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411.

Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, Nagano H, Hatano E, Izumi N, Kaneko S, Kudo M, Iijima H, Genda T, Tateishi R, Torimura T, Igaki H, Kobayashi S, Sakurai H, Murakami T, Watadani T, et al.

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines. Clin Pharmacol Ther. 2019 Oct;106(4):803-809.

Hirakawa A, Sudo K, Yonemori K, Sadachi R, Kinoshita F, Kobayashi Y, Okuma HS, Kawachi A, Tamura K, Fujiwara Y, Rubinstein L, Takebe N

Top tips in interventional oncology: palliative care. Endovascular Today. 2019;18(10):86-8.

Sone M, Arai Y

Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017

Marniza Saad, Adlinda Alip, Jasmine Lim, Matin Mellor Abdullah, Flora Li Tze Chong, Chong Beng Chua, Fuad Ismail, Rachael Kit-Tsan Khong, Chun Sen Lim, Chit Sin Loh, Rohan Malek, Khairul Asri Mohd Ghani, Ibtisam Md Noor, Noor Ashani Md Yusoff, Noor Azam Nasuha, Azad Razack, Hwoei Fen Soo Hoo, Murali Sundram, Pei Jye Voon, Teng Aik Ong

Evaluations of Biomarker Status Changes between Primary and Recurrent Tumor Tissue Samples in Breast Cancer Patients.” BioMed Research International. 2019. https://doi.org/10.1155/2019/7391237.

Nguyen Thi Hoa, et al.

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

Gwo-Fuang Ho, Chee-Shee Chai, Adlinda Alip, Mohd Ibrahim A Wahid, Matin Mellor Abdullah, Yoke-Ching Foo, Soon-Hin How, Adel Zaatar, Kai-Seng Lam, Kin-Wah Leong, John-Seng-Hooi Low, Mastura Md Yusof, Erica Chai-Yong Lee, Yok-Yong Toh, Chong-Kin Liam

Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project. Clin Pharmacol Ther. 2019 Sep;106(3):491-492.

Okuma HS, Fujiwara Y

Towards Circulating-Tumor DNA-Based Precision Medicine

Ai Hironaka-Mitsuhashi, Anna Sanchez Calle, Takahiro Ochiya, Shin Takayama, Akihiko Suto

ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities. FEBS Lett. 2019 Aug;593(16):2151-2161.

Yamamoto H, Hayakawa F, Yasuda T, Odaira K, Minamikawa Y, Tange N, Hirano D, Kojima Y, Morishita T, Tsuzuki S, Naoe T, Kiyoi H

Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis. JNCI Cancer Spectr. 2019 Aug 1;3(4):pkz057. doi: 10.1093/jncics/pkz057. eCollection 2019 Dec

de Rojas T, Neven A, Terada M, García-Abós M, Moreno L, Gaspar N, Péron J

Argon Plasma Coagulation With Cholangioscopy as Additional Treatment for Residual Ampullary Tumor in a Young Familial Adenomatous Polyposis Patient. ACG Case Rep J. 6(8): e00202

Cho Hourin, Yamada Masayoshi, Tanabe Noriko, Yoshida Teruhiko, Sugano Kokichi, Hashimoto Taiki, Hijioka Susumu

Local anesthesia with general anesthesia for pediatric bone marrow procedures. Pediatrics 2019;144 (2)

Zarnegar S,, Kange K, Mathias M, Nakajima-Hatano M, Offer K, et al.

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study

Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, Yasuo Hozumi, Yasuo Miyoshi, Hiroshi Yoshino, Hiroyoshi Doihara, Akihiko Suto, Motoshi Tamura, Takashi Morimoto, Hisamitsu Zaha, Takashi Chishima, Reiki Nishimura, Takashi Ishikawa, Yukari Uemura, Yasuo Ohashi

Post ESD bleeding prevention: Are polyglycolic acid sheets here to stay? Endoscopy. 2019 Jul;51(7):613-614.

Abe S

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.

Takahashi M, Miki S, Fujimoto K, Fukuoka K, Matsushita Y, Maida Y, et al.

Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan. Gastrointest Endosc. 2019 Jun;89(6):1120-1128.

Abe S, Ishihara R, Takahashi H, Ono H, Fujisaki J, Matsui A, Takahashi A, Goda K, Kawada K, Koike T, Takeuchi M, Tsuji Y, Hirasawa D, Oyama T

Incidence of Advanced Colorectal Neoplasia in Individuals with Untreated Diminutive Colorectal Adenomas Diagnosed by Magnifying Image-Enhanced Endoscopy. Am J Gastroenterol. 2019; 114: 964-73.

Sekiguchi M, Otake Y, Kakugawa Y, et al.

Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer

Kazuhiro Suzuki, Shoji Nagao, Takashi Shibutani, Kasumi Yamamoto, Tomoatsu Jimi, Hiroko Yano, Miho Kitai, Takaya ShiozakiKazuko Matsuoka 1, Satoshi Yamaguchi , Kazuko Matsuoka, Satoshi Yamaguchi

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Inagaki C, Shimoi T, Sumiyoshi Okuma H, Kawachi A, Sudo K, Shimomura A, Noguchi E, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Arakawa A, Ogawa C, Yoshida A, Fujiwara Y, Tamura K

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site.

Sato J, Shimoi T, Shimomura A, Noguchi E, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Fujiwara Y, Yoshida M, Tamura K

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

Sho Shiino, Juntaro Matsuzaki, Akihiko Shimomura, Junpei Kawauchi, Satoko Takizawa, Hiromi Sakamoto, Yoshiaki Aoki, Masayuki Yoshida, Kenji Tamura, Ken Kato, Takayuki Kinoshita, Yuko Kitagawa, Takahiro Ochiya

Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling. JAMA Netw Open. 2019;2(5):e194573. doi:10.1001/jamanetworkopen.2019.4573.

K Sudo, K Kato, J Matsuzaki, N Boku, S Abe, Y Saito, H Daiko, S Takizawa, Y Aoki, H Sakamoto, S Niida, F Takeshita, T Fukuda, T Ochiya

Biomarker discordance between primary breast cancer and bone or bone marrow metastases

Sayako Yuda, Chikako Shimizu, Masayuki Yoshida, Sho Shiino, Takayuki Kinoshita, Akiko Miyagi Maeshima, Kenji Tamura

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines. Clinical Pharmacology & Therapeutics. 2019;106 (4), 803-809.

A Hirakawa, K Sudo, K Yonemori, R Sadachi, F Kinoshita, Y Kobayashi, HS Okuma, A Kawachi, K Tamura, Y Fujiwara, L Rubinstein, N Takebe

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy. Ups J Med Sci. 2019;124(2):119-24.

Sone M, Arai Y, Sugawara S, Kubo T, Itou C, Hasegawa T, et al.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Cancer Sci 110:1464-1479, 2019

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Mano H, et al.

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study. Cancer science 110(4): 1480-1490 (2019)

Sunami Kuniko, Ichikawa Hitoshi, Kubo Takashi, Kato Mamoru, Fujiwara Yutaka, Shimomura Akihiko, Koyama Takafumi, Kakishima Hiroki, Kitami Mayuko, Matsushita Hiromichi, Furukawa Eisaku, Narushima Daichi, Nagai Momoko, Taniguchi Hirokazu, Motoi Noriko, Sekine Shigeki, Yonemori Kan , Tanabe Noriko , Yamamoto Noboru, Kohno Takashi, et al.

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials. Front Oncol 9:301, 2019

Koyama T, Kondo S, Shimizu T, Fujiwara Y, Morizane C, Sakamoto Y, Okusaka T, Yamamoto N

Evaluation of aprepitant and fosaprepitant in pediatric patients. Pediatric International 2019; 0:1-5

Saito Y, Kumamoto T, Arima T, Shirakawa N, Ishimaru S, Sonoda T, Nakajima M, Sugiyama M

Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.

Hirano D, Hayakawa F, Yasuda T, Tange N, Yamamoto H, Kojima Y, Morishita T, Imoto N, Tsuzuki S, Mano H, Naoe T, Kiyoi H

Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer

Sho Shiino, Masayuki Yoshida, Kenjiro Jimbo, Sota Asaga, Shin Takayama, Akiko Maeshima, Hitoshi Tsuda, Takayuki Kinoshita, Nobuyoshi Hiraoka

Characterization of MOSkin detector for in vivo dose verification during Cobalt-60 high dose-rate intracavitary brachytherapy

Zulaikha Jamalludin, Wei Loong Jong, Rozita Abdul Malik, Anatoly Rosenfeld, Ngie Min Ung

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Y-L Wu, D Planchard, S Lu, H Sun, N Yamamoto, D-W Kim, D S W Tan, J C-H Yang, M Azrif, T Mitsudomi, K Park, R A Soo, J W C Chang, A Alip, S Peters, J-Y Douillard

Moving towards tailored, region-specific cancer-control measures in China

Tomohiro Matsuda, Manami Inoue

Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study. Breast Cancer. 2019;26(1):39-46.

Noguchi E, Tamura K, Hattori M, Horiguchi J, Sato N, Kanatani K, Matsunaga K, Iwata H, Fujiwara Y

Responding to the challenges of international collaborations between the east and the west – report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators. Jpn J Clin Oncol. 2019 Jan 1;49(1):96-99. doi: 10.1093/jjco/hyy155.

Kataoka K, Kaider-Person O, Kasper B, Starlinger P, Caballero C, Menis J, Hendriks LE, Terada M, Collette L, Nakamura K, Lacombe D, Fukuda H

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J Thorac Oncol. 2019;14:377-407.

Yatabe Y, Dacic S, Borczuk AC, et al.

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA Asian subset. Journal of Thoracic Oncology. Thorac Oncol. 2019 Jan;14(1):99-106.

Young Chul Cho, Pei Jye Voon, et al.

Primary cardiac sarcomas: A multi-national retrospective review

Tom Wei-Wu Chen, Herbert H Loong, Amirrtha Srikanthan, Alona Zer, Reeta Barua, Jagdish Butany, Robert J Cusimano, Yun-Chieh Liang, Chin-Hao Chang, Zaza Iakobishvili, Albiruni R Abdul Razak, Jeremy Lewin

Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience

Nahjatul Kursyiah Abd Ghafar, Adlinda Alip, Teng Aik Ong, Ning Yi Yap, Marniza Saad

Immunotherapy for hepatocellular carcinoma: current status and future perspectives

Takuji Okusaka, Masafumi Ikeda

Right-Versus Left-Subclavian Central Venous Port for Patients with Malignant Tumor: A Retrospective Comparison of Adverse Events and Imaging Findings. Interventional Radiology. 2018;3:121-5.

Sone M, Arai Y, Sugawara S, Tomita K

High-throughput functional evaluation of variants of unknown significance in ERBB2. Clin Cancer Res. 24, 5112-5122, 2018.

Nagano M, Kohsaka S, Ueno T, et al.

Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report. Medicine (Baltimore). 2018;97(43):e12937.

Yano M, Asami Y, Nishikawa T, Yoshida S, Kamada K, Katoh T, et al.

Genomics of breast cancer applied to treatments

Diaddin Hamdan, Thi Thuy Nguyen, Van Tu Dao, Morad El Bouchtaoui, Anne Janin, Guilhem Bousquet

A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals. J Gastroenterol. 2018; 53: 1109-19.

Sekiguchi M, Kakugawa Y, Matsumoto M, et al.

Intersphincteric resection has similar long-term oncologic outcomes compared with abdominoperineal resection for low rectal cancer without preoperative therapy: results of propensity score analyses. Dis Colon Rectum. 2018 Sep; 61(9): 1035-1042

Shunsuke Tsukamoto, Mototaka Miyake, Dai Shida, Hiroki Ochiai, Kazunosuke Yamada, Yukihide Kanemitsu

Health-related quality of life and psychological distress among cancer survivors in a middle-income country

Shridevi Subramaniam, Yek-Ching Kong, Karuthan Chinna, Merel Kimman, Yan-Zheng Ho, Nadiah Saat, Rozita Abdul Malik, Nur Aishah Taib, Matin Mellor Abdullah, Gerard Chin-Chye Lim, Nor-Saleha Ibrahim Tamin, Yin-Ling Woo, Kian-Meng Chang, Pik-Pin Goh, Cheng-Har Yip, Nirmala Bhoo-Pathy

Pilot study on probe-based confocal laser endomicroscopy for colorectal neoplasms: an initial experience in Japan. Int J Colorectal Dis. 2018 Aug;33(8):1071-1078.

Abe S, Saito Y, Oono Y, Tanaka Y, Sakamoto T, Yamada M, Nakajima T, Matsuda T, Ikematsu H, Yano T, Sekine S, Kojima M, Yamagishi H, Kato H

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system. Cancer Sci. 2018;109(8):2558-66.

Shimoi T, Hamada A, Yamagishi M, Hirai M, Yoshida M, Nishikawa T, et al.

New developments in systemic therapy for advanced biliary tract cancer

Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights. Transl Lung Cancer Res. 2018 Aug;7(4):487-497.

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Establishing Cancer Treatment Programs in Resource-Limited Settings: Lessons Learned From Guatemala, Rwanda, and Vietnam

Claire M Wagner, Federico Antillón, François Uwinkindi, Tran Van Thuan, Sandra Luna-Fineman, Pham Tuan Anh, Tran Thanh Huong, Patricia Valverde, Arielle Eagan, Pham Van Binh, Tien Nguyen Quang, Sonali Johnson, Agnes Binagwaho, Julie Torode 1

A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018 Jun 12;2(11):1250-1258

Hoseini SS, Guo H, Wu Z, Hatano MN, Cheung NV, et al.

A systematic review of publications on charged particle therapy for hepatocellular carcinoma. Int J Clin Oncol. 2018 Jun;23(3):423-433. doi: 10.1007/s10147-017-1190-2. Epub 2017 Sep 4.

Igaki H, Mizumoto M, Okumura T, Hasegawa K, Kokudo N, Sakurai H

Dosimetric characterisation of the optically-stimulated luminescence dosimeter in cobalt-60 high dose rate brachytherapy system. Australasian physical & engineering sciences in medicine

M Rejab, J H D Wong, Z Jamalludin, W L Jong, R A Malik, W Z Wan Ishak, N M Ung

Evidence-based cancer prevention recommendations for Japanese

S Sasazuki, M Inoue, T Shimazu, K Wakai, M Naito, C Nagata, K Tanaka, I Tsuji, Y Sugawara, T Mizoue, K Matsuo, H Ito, A Tamakoshi, N Sawada, T Nakayama, Y Kitamura, A Sadakane, S Tsugane

YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC, Cancer Res. 2018 Jun 15;78(12):3306-3320

Wonyoung Choi, Jeongsik Kim, Jaeoh Park, Da-Hye Lee, Daehee Hwang, Jeong-Hwan Kim, Hassan Ashktorab, Duane Smoot, Seon-Young Kim, Chan Choi, Gou Young Koh, Dae-Sik Lim

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma. Ther Innov Regul Sci. 2018;52(3):334-8.

Hirakawa A, Nishikawa T, Yonemori K, Shibata T, Nakamura K, Ando M, et al.

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib. J Thorac Oncol. 2018 May;13(5):727-731

Yoshihisa Kobayashi, Toshio Fujino, Masaya Nishino, Takamasa Koga, Masato Chiba, Yuichi Sesumi, Shuta Ohara, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Tetsuya Mitsudomi

Two cases of malignant adenomyoepithelioma of the breast. Journal of Japan Surgical Association. 2018:79(2):294-301

Momoko Tokura, Yoko Omi, Eiichiro Noguchi, Tomoko Yamamoto, Takako Kamio, Takahiro Okamoto

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève, Olufemi J Ogunbiyi, Gulnar Azevedo E Silva, Wan-Qing Chen, Sultan Eser, Gerda Engholm, Charles A Stiller, Alain Monnereau, Ryan R Woods, Otto Visser, CONCORD Working Group, et al.

Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018; 20(3): 332-343

Zhang H, Freitas D, Nakajima M, et al.

Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study. Surg Today. 2018, Mar;48(3):325-332. doi: 10.1007/s00595-017-1592-9.

Terada M, Kinoshita T, Kaito A, Sugita S, Watanabe M, Hayashi R

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

Tom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, Ching-Hung Lin, Louis Wing-Cheong Chow, Dwan-Ying Chang, Yao-Yu Hsieh, Shu-Min Huang, Ann-Lii Cheng, Yen-Shen Lu, Taiwan Breast Cancer Consortium

Expression of angiogenic factors in sclerosing stromal tumours of the ovary.

Hirakawa T, Kawano Y, Mizoguchi C, Nasu K, Narahara H

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Rossanna C Pezo, Tom W Chen, Hal K Berman, Anna M Mulligan, Albiruni A Razak, Lillian L Siu, David W Cescon, Eitan Amir, Christine Elser, David G Warr, Srikala S Sridhar, Celeste Yu, Lisa Wang, Tracy L Stockley, Suzanne Kamel-Reid, Philippe L Bedard

A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

Tetsuya Sasaki, Yasuhisa Kato, Atsushi Sato, Noriko Usui, Eishi Baba, Toshimi Takano, Nobuyuki Susumu, Kazunori Ohnishi, Hitomi Nishimoto, Katsuyuki Kiura

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer. N Engl J Med. 2018 Jan 11;378(2):113-125.

Jean-Charles Soria, Pei Jye Voon, et al.

Triple negative breast cancer: The molecular classification

Tu V Dao, Anh V Nguyen, Hieu V Nguyen, Quang V Le

A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer. Sci Transl Med. 9, eaan6566, 2017.

Kohsaka S, Nagano M, Ueno T, et al.

Approaches for stricture prevention after esophageal endoscopic resection. Gastrointest Endosc. 2017 Nov;86(5):779-791.

Abe S, Prasad G Iyer, Oda I, Kanai N, Saito Y

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. Lancet Oncol. 2017 Nov;18(11):1512-1522.

Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, Shimizu C, Shimoi T, Kuboki Y, Matsubara N, Kitano A, Jikoh T, Lee C, Fujisaki Y, Ogitani Y, Yver A, Tamura K

A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer. Sci Transl Med 9:eaan6556, 2017

Kohsaka S, Nagano M, Ueno T, Suehara Y, Hayashi T, Shimada N, Takahashi K, Suzuki K, Takamochi K, Takahashi F, Mano H

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study.

Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, Shimizu C, Shimoi T, Kuboki Y, Matsubara N, Kitano A, Jikoh T, Lee C, Fujisaki Y, Ogitani Y, Yver A, Tamura K

Laparoscopic Abdominoperineal Resection for Low Rectal Cancer at National Cancer Hospital of Vietnam

Binh V. Pham, Anh T. Pham, Su Bin Kim, Tran Van Thuan, Nguyen Tien Quang

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.

Kasumi Yamamoto, Shoji Nagao, Kazuhiro Suzuki, Ai Kogiku, Tokihiro Senda, Hiroko Yano, Miho Kitai, Takaya Shiozaki, Kazuko Matsuoka, Satoshi Yamaguchi

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors. Cancer Sci. 2017;108(9):1834-42.

Nishikawa T, Matsumoto K, Tamura K, Yoshida H, Imai Y, Miyasaka A, et al.

Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators

F Moradi, N M Ung, M U Khandaker, G A Mahdiraji, M Saad, R Abdul Malik, A Z Bustam, Z Zaili, D A Bradley

Rare presentation of idiopathic duodenoduodenal intussusception

G H Loo, W M Mohamad Abu Zeid, S L Lim, A M Ismail

Anti-Cancer Vaccines in Pediatrics In: Immunotherapy for Pediatric Malignancies. Springer, 2017.

Nakajima M, Modak, S

YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma. Pharmacol Res. 2017 Jun;120:242-251.

Kojima Y, Hayakawa F, Morishita T, Sugimoto K, Minamikawa Y, Iwase M, Yamamoto H, Hirano D, Imoto N, Shimada K, Okada S, Kiyoi H

BRCA Gene Mutations and Poly(ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer. Adv Exp Med Biol. 2017;1026:271-286.

Okuma HS, Yonemori K

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer

Takuji Okusaka, H Miyakawa, H Fujii, S Nakamori, T Satoh, Y Hamamoto, T Ito, H Maguchi, S Matsumoto, H Ueno, T Ioka, N Boku, S Egawa, T Hatori, J Furuse, K Mizumoto, S Ohkawa, T Yamaguchi, K Yamao, A Funakoshi, et al.

Comparison of the clinical results of abdominoperanal intersphincteric resection and abdominoperineal resection for lower rectal cancer. Int J Colorectal Dis. 2017 Jan

Shunsuke Tsukamoto, Yukihide Kanemitsu, Dai Shida, Hiroki Ochiai, Junichi Mazaki

Clinical outcomes and prognostic factors in gastric cancer patients aged ≥85 years undergoing endoscopic submucosal dissection. Gastrointest Endosc. 2017; 85: 963-72.

Sekiguchi M, Abe S , Oda I, Suzuki H, et al.

A case of “adenomatous goiter” with multiple distant metastases after surgery. Journal of the Japan Thyroid Association. 2017:8(1):51-54

Momoko Sakurai, Kento Haniu, Erin Nagai, Hiroki Tokumitsu, Yusaku Yoshida, Yoko Omi, Akiko Sakamoto, Kiyomi Horiuchi, Takahiro Okamoto, Tatsuo Sawada, Yoji Nagashima

Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer. Clin Lung Cancer. 2017 Mar;18(2):234-240.

Okuma HS, Horinouchi H, Kitahara S, et al.

Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism. Oncotarget. 2017 Feb 21;8(8):13085-13098.

Aoki T, Shimada K, Sakamoto A, Sugimoto K, Morishita T, Kojima Y, Shimada S, Kato S, Iriyama C, Kuno S, Harada Y, Tomita A, Hayakawa F, Kiyoi H

Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer. Mol Cancer Ther. 2017 Feb;16(2):357-364.

Yoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai, Young Hak Kim, Yosuke Togashi, Yuichi Sesumi, Masato Chiba, Masaki Shimoji, Katsuaki Sato, Kenji Tomizawa, Toshiki Takemoto, Kazuto Nishio, Tetsuya Mitsudomi

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC

Yi-Long Wu, Nagahiro Saijo, Sumitra Thongprasert, J C-H Yang, Baohui Han, Benjamin Margono, Busayamas Chewaskulyong, Patrapim Sunpaweravong, Yuichiro Ohe, Yukito Ichinose, Jin-Ji Yang, Tony S K Mok, Helen Young, Vincent Haddad, Yuri Rukazenkov, Masahiro Fukuoka

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.

Natasha B Leighl, Naiyer A Rizvi, Lopes Gilberto de Lima Jr, Wichit Arpornwirat, Charles M Rudin, Alberto A Chiappori, Myung-Ju Ahn, Laura Q M Chow, Lyudmila Bazhenova, Arunee Dechaphunkul, Patrapim Sunpaweravong, Keith Eaton, Jihong Chen, Sonja Medley, Shirish M Gadgeel, et al.

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study. J Gynecol Oncol. 2017;28(1):e25.

Nishikawa T, Hasegawa K, Yabuno A, Yoshida H, Yasuda M, Kozawa E, et al.

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial

Hope S Rugo, Abhijit Barve, Cornelius F Waller, Miguel Hernandez-Bronchud, Jay Herson, Jinyu Yuan, Rajiv Sharma, Mark Baczkowski, Mudgal Kothekar, Subramanian Loganathan, Alexey Manikhas, Igor Bondarenko, Guzel Mukhametshina, Gia Nemsadze, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Kakhaber Baramidze, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, et al.

From a Comic Opera to Surcare an Open Letter to Whom Clinical Research in Surgery Is a Concern: Announcing the Launch of SURCARE. Ann Surg 2016; 264: 911-912.

Evrard S, Audisio R, Poston G, Caballero C, Kataoka K, Fontein D, Collette L, Nakamura K, Fukuda H, Lacombe D

Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment

Takuji Okusaka, Taiga Otsuka, Hideki Ueno, Shuichi Mitsunaga, Rie Sugimoto, Kei Muro, Isao Saito, Yusuke Tadayasu, Kohei Inoue, Arsene-Bienvenu Loembé, Masafumi Ikeda

In vivo skin dose measurement using MOSkin detectors in tangential breast radiotherapy

W L Jong, N M Ung, J H D Wong, K H Ng, W Z Wan Ishak, R Abdul Malik, V C E Phua, D L Cutajar, P E Metcalfe, A B Rosenfeld, G F Ho

Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. J Gastroenterol. 2016; 51: 961-70.

Sekiguchi M, Oda I, Taniguchi H, et al.

Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy. Cancer Sci. 2016 Sep;107(9):1179-86.

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Angio-CT–Assisted Balloon Dissection: Protection of the Adjacent Intestine during Cryoablation for Patients with Renal Cancer. Journal of Vascular and Interventional Radiology. 2016;27(9):1414-9.

Sone M, Arai Y, Sugawara S, Tomita K, Fujiwara K, Ishii H, et al.

SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis)

Chanida Vinayanuwattikun, Siyamol Mingmalairak, Nutchawan Jittapiromsak, Iyavut Thaipisuttikul, Virote Sriuranpong, Apiwat Mutirangura, Shanop Shuangshoti

The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib. Oncotarget. 2016 Aug 30;7(35):56241-56252.

Morishita T, Hayakawa F, Sugimoto K, Iwase M, Yamamoto H, Hirano D, Kojima Y, Imoto N, Naoe T, Kiyoi H

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies. Br J Cancer. 2016 Aug 9;115(4):411-9.

Okuma HS, Koizumi F, Hirakawa A

Disseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: A report of three cases. Oncol Lett. 2016 Aug;12(2):809-814.

Okuma HS, Kobayashi Y, Makita S, et al.

Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann. Surg. 2016, 264 (2), 214-22.

Honda, M, Hiki, N, Yabusaki, H, Abe, T, Nunobe, S, Terada, M, Matsuki, A, Sunagawa, H, Aizawa, M, Healy, M. A, Iwasaki, M, Furukawa, T. A

Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma

Chanida Vinayanuwattikun, Florence Le Calvez-Kelm, Behnoush Abedi-Ardekani, David Zaridze, Anush Mukeria, Catherine Voegele, Maxime Vallée, Dewajani Purnomosari, Nathalie Forey, Geoffroy Durand, Graham Byrnes, James Mckay, Paul Brennan, Ghislaine Scelo

Intravenous leiomyomatosis treated with radical hysterectomy and adjuvant aromatase inhibitor therapy.

Chiharu Mizoguchi, Harunobu Matsumoto, Kaei Nasu, Motoki Arakane, Kentaro Kai, Hisashi Narahara

Sorafenib Acts through VEGFR-2 Inhibition in a Metastatic Clear-Cell Sarcoma of the Kidney

Tu V. Dao, Thuan V Tran, Christophe Lebœuf, Morad El-Bouchtaoui, Jérôme Verine, Anne Janin, Guilhem Bousquet

Radioiodine ablation as a post-operative adjuvant therapy for thyroid cancer. 2016:77(12):2875-2880

Omi Yoko, Kento Haniu, Momoko Sakurai, Erin Nagai, Hiroki Tokumitsu, Yusaku Yoshida, Akiko Sakamoto, Kiyomi Horiuchi, Takahiro Okamoto, Kenji Fukushima, Kouichiro Abe

Young Lady With Recurrent Abdominal Pain, Is It Only Gastritis?

Neoh KK, Tang ASN, Kiing JW, Adam Malik I

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet 48:569-74, 2016

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Mano H, et al.

Trends in the development of MET inhibitors for hepatocellular carcinoma. Future Oncol. 2016 May;12(10):1275-86.

Okuma HS, Kondo S

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nature Genetics. 48, 569-574, 2016.

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, et al.

Novel combination of serum microRNA for detecting breast cancer in the early stage

Akihiko Shimomura, Sho Shiino, Junpei Kawauchi, Satoko Takizawa, Hiromi Sakamoto, Juntaro Matsuzaki, Makiko Ono, Fumitaka Takeshita, Shumpei Niida, Chikako Shimizu, Yasuhiro Fujiwara, Takayuki Kinoshita, Kenji Tamura, Takahiro Ochiya

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016; 17: 309-318.

Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, Iwasaki Y, Hyung WJ, Takagane A, Park DJ, Yoshikawa T, Hahn S, Nakamura K, Park CH, Kurokawa Y, Bang YJ, Park BJ, Sasako M, Tsujinaka T, investigators Rs

Surgical Outcomes of Laparoscopic Gastrectomy for Obese Patients with Body Mass Indices of >=30 kg/m2. Journal of Tokyo Women’s Medical University. 2016:86(4):147-151

Momoko Sakurai, Kazuhito Yajima, Ken Yuu, Ryouki Oohinata, Satoshi Ishiyama, Yoshiaki Iwasaki

B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia. J Biol Chem. 2016 Feb 26;291(9):4723-31.

Imoto N, Hayakawa F, Kurahashi S, Morishita T, Kojima Y, Yasuda T, Sugimoto K, Tsuzuki S, Naoe T, Kiyoi H

A nomogram to predict distant metastases after multimodality therapy for patients with localized esophageal cancer. Journal of the National Comprehensive Cancer Network.: JNCCN. 2016;14(2):173-179.

K Sudo, X Wang, L Xiao, R Wadhwa, H Shiozaki, E Elimova, DC Rice, JH Lee, B Weston, MS Bhutani, A Hiremath, N Charalampakis, R Komaki, MA Blum, SG Swisher, DM Maru, HD Skinner, JL Garris, JE Rogers, WL Hofstetter, et al.

Dosimetric impact of applicator displacement during high dose rate (HDR) Cobalt-60 brachytherapy for cervical cancer: A planning study

J. S. Yong, N. M. Ung, Z. Jamalludin, R. A. Malik, J. H. D. Wong, Y. M. Liew, K. H. Ng

Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data. Jpn J Clin Oncol. 2016; 46: 116-25.

Sekiguchi M, Igarashi A, Matsuda T, et al.

Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy. 2015 Dec;47(12):1113-8.

Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Nakajima T, Sekiguchi M, Mori G, Taniguchi H, Sekine S, Katai H, Saito Y

Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma

Takuji Okusaka, Hideki Ueno, Masafumi Ikeda, Shuichi Mitsunaga, Masato Ozaka, Hiroshi Ishii, Osamu Yokosuka, Yoshihiko Ooka, Ryo Yoshimoto, Yasuo Yanagihara, Kiwamu Okita

EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs. Clin Cancer Res. 2015 Dec 1;21(23):5305-13.

Yoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, Hiroshi Mizuuchi, Park Jangchul, Chiaki Kondo, Masaki Shimoji, Kenichi Suda, Kenji Tomizawa, Toshiki Takemoto, Toyoaki Hida, Kazuto Nishio, Tetsuya Mitsudomi

Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion. J Gastroenterol. 2015; 50: 1184-9.

Sekiguchi M, Sekine S, Sakamoto T, et al.

Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A). Gastric Cancer 2015; 18: 597-604.

Nakamura K, Kuwata T, Shimoda T, Mizusawa J, Katayama H, Kushima R, Taniguchi H, Sasako M, Fukuda H

Comprehensive Genomic Profiles of Small Cell Lung Cancer. Nature. 2015;524:47-53.

George J, Lim JS, Jang SJ, Yatabe Y, Thomas RK

Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines. Japanese journal of radiology. 2015;33(4):233-40.

Sone M, Nakajima Y, Woodhams R, Shioyama Y, Tsurusaki M, Hiraki T, et al.

Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. Ann Oncol. 2015 Jan;26(1):156-161.

Kobayashi Y, Mitsudomi T, Sakao Y, Yatabe Y

Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer

Krittiya Korphaisarn, Ananya Pongpaibul, Chanin Limwongse, Ekkapong Roothumnong, Wipawi Klaisuban, Akarin Nimmannit, Artit Jinawath, Charuwan Akewanlop

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer. 2014;120 (23), 3635-3641.

HD Skinner, JH Lee, MS Bhutani, B Weston, W Hofstetter, R Komaki, H Shiozaki, R Wadhwa, K Sudo, E Elimova, S Song, Y Ye, M Huang, J Ajani, X Wu

Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. Journal of Clinical Oncology. 2014;32 (30), 3400.

K Sudo, L Xiao, R Wadhwa, H Shiozaki, E Elimova, T Taketa, MA Blum, JH Lee, MS Bhutani, B Weston, WA Ross, R Komaki, DC Rice, SG Swisher, WL Hofstetter, DM Maru, HD Skinner, JA Ajani

Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. Anticancer Res. 2014 Sep;34(9):5037-41.

Okuma HS, Iwasa S, Shoji H

A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan. Familial Cancer 13(3):489-498(2014)

Noriko Ando-Tanabe, Ayumi Shikama, Hiroko Bando, Toyomi Satoh, Chikako Shimizu

Percutaneous creation of an extraanatomic splenoportal shunt in a patient with bleeding ectopic varices. J Vasc Interv Radiol. 2014;25(8):1301-3.

Sone M, Arai Y, Morita S, Tomimatsu H, Sugawara S, Ishii H, et al.

Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells. Cancer Res. 2014;74 (15), 4170-4182.
The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence

Chanida Vinayanuwattikun, Poonchavist Chantranuwat, Virote Sriuranpong, Apiwat Mutirangura

Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer 21:453-462(2014)

Noriko Ando-Tanabe, Yumi Iwamitsu, Masaru Kuranami, Shigemi Okazaki, Hiroe Yasuda, Yuki Nakatani, Kenji Yamamoto, Masahiko Watanabe, Hitoshi Miyaoka

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K/AKT pathway mutations. Nature Genetics. 46, 595-600, 2014.

Kohsaka S, et al.

Recurrent immature teratoma of the ovary with long-term disease-free interval.

Matsumoto H, Mizoguchi C, Nishida M, Sato S, Nasu K, Narahara H

Era of comprehensive cancer genome analyses. J Clin Oncol 32:4029-30, 2014 (editorial)

Yatabe Y, Thomas RK

Clinical Outcomes of AIDS-related Burkitt Lymphoma: A Multi-institution in Japan. Jpn J Clin Oncol. 2014 Apr;44(4):318-23

Kojima Y, Hagiwara S, Uehira T, Ajisawa A, Kitanaka A, Tanuma J, Okada S, Nagai H

Percutaneous catheter and port placement for hepatic arterial infusion chemotherapy: catheter placement from subclavian artery. J Vasc Interv Radiol. 2014;25(4):577.

Sone M, Arai Y, Okamoto D, Ishii H, Sugawara S, Morita S, et al.

CD74-NRG1 Fusions in Lung Adenocarcinoma. Cancer Discov, 2014. 4(4): p. 415-22.

Fernandez-Cuesta L, Yatabe Y, Thomas R

ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Molecular oncology. 2014;8 (1), 142-149.

JA Ajani, X Wang, S Song, A Suzuki, T Taketa, K Sudo, R Wadhwa, WL Hofstetter, R Komaki, DM Maru, JH Lee, MS Bhutani, B Weston, V Baladandayuthapani, Y Yao, S Honjo, AW Scott, HD Skinner, RL Johnson, D Berry

A Newly Introduced Comprehensive Consultation fee in the National Health Insurance System in Japan: A Promotive Effect of Multidisciplinary Medical Care in the Field of Radiation Oncology--Results from a Questionnaire Survey. Jpn J Clin Oncol 2013 Dec;43(12):1233-1237. doi: 10.1093/jjco/hyt147. Epub 2013 Sep 25.

Igaki H, Onishi H, Nakagawa K, Dokiya T, Nemoto K, Shigematsu N, Nishimura Y, Hiraoka M, et al.

Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. Journal of clinical oncology. 2013;31 (34), 4306.

K Sudo, T Taketa, AM Correa, MC Campagna, R Wadhwa, MA Blum, R Komaki, JH Lee, MS Bhutani, B Weston, HD Skinner, DM Maru, DC Rice, SG Swisher, WL Hofstetter, JA Ajani

EGFR Exon 20 Insertion A763-Y764insFQEA and response to Erlotinib. Molecular Cancer Therapeutics. Volume 12, Issue 11, pp. 2614-2615.

Pei Jye Voon, et al.

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

David Miles, José Baselga, Dino Amadori, Patrapim Sunpaweravong, Vladimir Semiglazov , Adam Knott, Emma Clark, Graham Ross, Sandra M Swain

Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)

Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, Atsuo Takashima, Makoto Ueno, Masafumi Ikeda, Yasuo Hamamoto, Hiroshi Ishii, Narikazu Boku, Junji Furuse

Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer

Tetsuya Sasaki, Ken-Ichi Fujita, Yu Sunakawa, Hiroo Ishida, Keishi Yamashita, Keisuke Miwa, Shigehira Saji, Yasuhisa Kato, Yasutsuna Sasaki

Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int J Colorectal Dis. 2014 Jan; 29(1)81-7

Shunsuke Tsukamoto, Yusuke Kinugasa, Tomohiro Yamaguchi, Akio Shiomi

Correlation of Aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. Br J Clin Pharmacol. 2013 Jun;75(6): 1497-505. doi.org/10.1111/bcp.12021

Pei Jye Voon, et al.

Job satisfaction, income, workload, workplace, and demographics of Japanese radiologists in the 2008 survey. Jpn J Radiol. 2013;31(5):364-70.

Sone M, Mizunuma K, Nakajima Y, Yasunaga H, Ohtomo K.

Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.  Annals of oncology. 2013;24 (5), 1262-1266.

NKS Cheedella, A Suzuki, L Xiao, WL Hofstetter, DM Maru, T Taketa, K Sudo, MA Blum, SH Lin, J Welch, JH Lee, MS Bhutani, DC Rice, AA Vaporciyan, SG Swisher, JA Ajani

Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma. Br J Surg. 100(6):801-7. 2013

Esaki M, Shimada K, et al.

Surgery for NSCLC in the era of personalized medicine, Nat Rev Clin Oncol 2013, 10:235-244

Mitsudomi T, Suda K, Yatabe Y

How long should small lung lesions of ground glass opacity be followed? Journal of Thoracic Oncology (2013) 8(3): 309-14.

Kobayashi Y, Fukui T, Ito S, Usami N, Hatooka S, Yatabe Y, Mitsudomi T

A case of a difficult preoperative diagnosis for a middle-aged male with solid-pseudopapillary neoplasm. Suizo. 2013 Jan; 28(5): 636-642. doi: 10.2958/suizo.28.636

Shunsaku Homma, Kentaro Yasuchika, Mitsumi Terada, Tadashi Ito

A retrospective analysis of adverse reactions induced by high therapy in hematological malignancies-dose methotrexate. The Journal of Tokyo Medical University. 70(4), 430-439, 2012.

Yoichi Osato, Tomohisa YOKOYAMA, Motoyo ROKUTANI, Chinatsu IGA, Yui KUROKAWA, Asako GONDO, Hiroaki FUJIMOTO, Kazuma OHYASHIKI

Proper use of antiemetic drugs in an outpatient chemotherapy center. The Journal of Tokyo Medical University. 70(1), 15-25, 2012.

Tetsuya ABE, Tomohisa YOKOYAMA, Yui KUROKAWA, Hiroko HAYABE, Akime MIYASATO, Yoichi Osato, Yasuyo SUZUKI, Kazuma OHYASHIKI

Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A). Jpn J Clin Oncol 2012; 42: 896-902.

Nakamura K, Shibata T, Takashima A, Yamamoto S, Fukuda H

Assessment of health-related quality of life in cancer outpatients treated with chemotherapy. (In Japanese with English abstract). Gan-to-Kagakuryohou, 39 (3), 409 – 414 (2012).

Tomohisa Yokoyama, Yuri Kurokawa, Rinako Kani, E Takatori, S Nokiguchi, Y Suzuki, Yoichi Osato, H Kawashima, M Uenishi, H Miyamatsu, A Sofuni, T Itoi, N Ikeda, K Ohyashiki

CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients.

Ekaphop Sirachainan, Sureerat Jaruhathai, Narumol Trachu, Ravat Panvichian, Thitiya Sirisinha, Touch Ativitavas, Vorachai Ratanatharathorn, Montri Chamnanphon, Chonlaphat Sukasem

Assessment of psychological distress in cancer outpatients treated with chemotherapy. (In Japanese with English abstract). Gan-to-Kagakuryohou, 39 (3), 415 – 419 (2012).

T Yokoyama, A Murakoshi, Y Kurokawa, R Kani, Yoichi Osato, H Miyamatsu, A Sofuni, T Itoi, K Yamada, N Ikeda, M Iimori, K Ohyashiki

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis. Cancer Chemother Pharmacol. 2012 9 70:391-397

Kojima Y, Hashimoto K, Ando M, Yonemori K, Yamamoto H, Kodaira M, Yunokawa M, Shimizu C, Tamura K, Hosono A, Makimoto A, Fujiwara Y

Pharmacogenetic Study of 5-Fluorouracil-Related Severe Toxicity in Thai Cancer Patients: A Novel SNP Detection

Sirachainan E, et al.

ALKoma: a cancer subtype with a shared target. Cancer Discov 2:495-502, 2012

Mano H

RET, ROS1 and ALK fusions in lung cancer. Nat Med 18:378-81, 2012

Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y

A retrospective analysis of neurotoxicity induced by vinca alkaloids combined with azole anti-fungal agents in hematological malignancies. Gan-to-Kagakuryohou, 38 (10), 1667 – 1672 (2011).

Yoichi Osato, Tomohisa YOKOYAMA, Yumiko Saito, Rinako Kani, Hiroko Hayabe, Hironobu Miyamatsu, Kazuma Ohyashiki

Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints. Familial Cancer 10(4): 681-689 (2011)

Noriko Ando, Yumi Iwamitsu, Masaru Kuranami, Shigemi Okazaki, Kenji Yamamoto, Masahiko Watanabe, Hitoshi Miyaoka

Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer

Chanida Vinayanuwattikun, Virote Sriuranpong, Suebpong Tanasanvimon, Poonchavist Chantranuwat, Apiwat Mutirangura

Heterogeneous distribution of the EGFR mutation is extremely rare in lung adenocarcinoma. J Clin Oncol 2011;29:2972-7

Yatabe Y, Matsuo K, Mitsudomi T

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.

Tanadech Dechaphunkul, Kowit Pruegsanusak, Duangjai Sangthawan, Patrapim Sunpaweravong

Clinical significance of osteoprotegerin expression in human colorectal cancer. Clinical Cancer Research. 2011 Apr 15; 17(8):2444-50.

Shunsuke Tsukamoto, Toshiaki Ishikawa, Satoru Iida, Megumi Ishiguro, Kaoru Mogushi, Hiroshi Mizushima, Hiroyuki Uetake, Hiroshi Tanaka, Kenichi Sugihara

Predictors of psychological distress after diagnosis in breast cancer patients and patients with benign breast problems. Psychosomatics Jan-Feb; 52(1):56-64 (2011)

Noriko Ando, Yumi Iwamitsu, Masaru Kuranami, Shigemi Okazaki, Yuki Nakatani, Kenji Yamamoto, Masahiko Watanabe, Hitoshi Miyaoka

Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg. 98(1):117-123. 2011.

Shimada K, et al.

Think about multi-disciplinary care –Visits to M. D. Anderson cancer center-. (In Japanese with English abstract), Jpn J Cancer Chemother 37(4): 753-757, 2010.

Naoko Sugiyama, Atsuo Takashima, Hironobu Hashimoto, Yoichi Osato, Sayuri Kitayama, Hitomi Sato, Naoto T. Ueno

The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey.

Yew Oo Tan, Sehwan Han, Yen-Shen Lu, Cheng-Har Yip, Patrapim Sunpaweravong, Joon Jeong, Priscilla B Caguioa, Shyam Aggarwal, Ee Min Yeoh, Hanlim Moon

Phase I/II multiinstitutional study of uterine artery embolization with gelatin sponge for symptomatic uterine leiomyomata: Japan Interventional Radiology in Oncology Study Group (JIVROSG) study. J Vasc Interv Radiol. 2010;21(11):1665-71.

Sone M, Arai Y, Shimizu T, Takeuchi Y, Higashihara H, Ohgi S

Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model. Cardiovasc Intervent Radiol. 2010;33(5):1001-8.

Sone M, Osuga K, Shimazu K, Higashihara H, Nakazawa T, Kato K, et al.

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. N Engl J Med 363:1734-9, 2010

Choi YL, Soda M, Yamashita Y, Ueno T, Takashima J, Nakajima T, Yatabe Y, Takeuchi K, Hamada T, Haruta H, Ishikawa Y, Kimura H, Mitsudomi T, Tanio Y, Mano H

The role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of advanced stage non-small cell lung cancer. J Thorac Dis 2010. J Thorac Dis. 2010 Sep; 2(3): 144–153.

Pei Jye Voon, et al.

Gefitinib versus cisplatin/docetaxel in patients with non-small cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): a randomised phase III trial. Lancet Oncol 2010; 11: 121-128

Mitsudomi T, Morita S, Yatabe Y, et al.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose, Yutaka Nishiwaki, Yuichiro Ohe, Jin-Ji Yang, Busyamas Chewaskulyong, Haiyi Jiang, Emma L Duffield, Claire L Watkins, Alison A Armour, Masahiro Fukuoka

Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 145(4):411-6. 2009

Shimada K, et al.

Management of side effects of Docetaxel, Estramustine, and hydrocortisone for hormontherapy resistant prostate cancer.  (In Japanese with English abstract) , Japan Society of Hospital Pharmacists 44(9); 1397-1400; 2008

Tomomi Omori, Kanako Azuma, Hironobu Miyamatsu, Yoichi Osato, Yoshihiro Nakagami, Masaki Tachibana, Takao Akashi

Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors. Int J Colorectal Dis. 2008 Nov; 23(11):1109-13.

Shunsuke Tsukamoto, Shin Fujita, Tomohiro Yamaguchi, Seiichiro Yamamoto, Takayuki Akasu, Yoshihiro Moriya, Hirokazu Taniguchi, Tadakazu Shimoda

Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455:971-4, 2008

Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S

Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg. 195(6):775-81. 2008

Shimada K, et al.

Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res 2008;68:2106-11.

Yatabe Y, Takahashi T, Mitsudomi T

Brain metastases after achieving local pathological complete responses with neoadjuvant chemotherapy. Breast Cancer. 2007; 14(4):420-4.

Shunsuke Tsukamoto, Sadako Akashi-Tanaka, Tadahiko Shien, Kotoe Terada, Takayuki Kinoshita

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561-6, 2007

Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H

Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 14(8):2337-47. 2007

Shimada K, et al.

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

T Hamaguchi, K Kato, H Yasui, C Morizane, M Ikeda, H Ueno, K Muro, Y Yamada, T Okusaka, K Shirao, Y Shimada, H Nakahama, Y Matsumura

Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol. 13(12):1569-78. 2006

Shimada K, et al.

Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 139(3):288-95. 2006

Shimada K, et al.

The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg. 203(3):345-52. 2006

Shimada K, et al.

A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer. 104(9):1939-47. 2005

Shimada K, et al.

Preoperative chemoradiotherapy in locally advanced rectal cancer: Ramathibodi experience

Ekaphop Sirachainan, Kanit Sumboonnanonda, Somjai Dangprasert, Ravat Panvichian, Thitiya Sirisinha, Mantana Dhanachai, Virat Pairachvet, Puangtong Kraiphibul, Vorachai Ratanatharathorn

Recent developments in critical genes in the molecular biology of breast cancer.

Somkiat Sunpaweravong, Patrapim Sunpaweravong

Unusual presentations of lung cancer: case 2. Adrenal insufficiency as the initial manifestation of non-small-cell lung cancer.

Ekaphop Sirachainan, Gregory P Kalemkerian

Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody

C Akewanlop, M Watanabe, B Singh, M Walker, D W Kufe, D F Hayes

学会発表

Testicular germ cell tumour presenting as lung metastasis with histological discordance between primary and metastatic tumour. A case report

Lee Fong Wan, et al.

Abdominal Actinomyces infection simulating malignant neoplasm. A case report

Lee Fong Wan, et al.

A Retrospective Review of Mucinous Borderline Ovarian Tumor at tertiary hospital, Thailand; Oncologic Outcomes Including Important Risk Factors (In process of submission, JGO poster presentation)

Poonyakanok V, Chaopotong P, Warnnissorn M

Efficacy, safety, and patient-report outcome atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in Thailand: multicenter prospective study

Ekaphop Sirachainan

Clinical treatment score post-5 years (CTS5) as a tool for risk estimation of late recurrence in Thai patients with estrogen receptor positive, early breast cancer: A validation study

P. Patanayindee, T. Dejthevaporn

Diagnostic Accuracy of the NCCN Distress Thermometer for the Assessment of the Psychosocial Distress among Filipino Patients with Cancer.

Dean Marvin P. Pizarro, Marie Belle I. Francia, Mel Valerie C. Ordinario

Use of immersive virtual reality for management of anxiety and depression among chemotherapy-naïve Filipino breast cancer outpatients in a national university hospital. Annals of Oncology, Volume 32, Supplement 5, S1193 (2021).

Ando M, Leones LM, Mendoza MJ, Ting FI, Sacdalan DB

Clinicopathologic Features and Survival of Filipino Women with Triple-Negative Breast Cancer: A Single-Center Experience Annals of Oncology, Volume 32, Supplement 4, S307 (2021).

Ando M, Uson AJ

Metastatic Spinal Cord Compression Caused by Recurrent Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland Annals of Oncology, Volume 32, Supplement 4, S358 (2021).

Ando M, San Juan M

Neoadjuvant immunotherapy plus chemotherapy in early triple negative breast cancer: a meta-analysis of randomized controlled trials.

J.G.P.Pandy, M.V.C.Ordinario, M.J.E.Alcantara, R.K.Li

Triple Negative Breast Cancer and Platinum-Based Treatment: Meta-analysis and Systematic Review.

Jessa Gilda P Pandy, Joanmarie C Balolong-Garcia, Mel Valerie B Cruz-Ordinario, Frances Victoria F Que

Comparison of ddPCR and qPCR for Detection of EGFR Mutations in Plasma Cell-Free DNA in Lung Adenocarcinoma.

J. Uyboco, M.S. Aguilera, J.J. Andal, V. Dy, M.V. Cruz-Ordinario, R. Li, D. Ang

Metastasis invasive thymoma to the brain as posterior fossa mass. A case report

Lee Fong Wan, et al.

A Large Adrenal Mass with Neuroendocrine Features Presenting as Pulmonary Embolism: A Case Report

Johanna Lu, Mel Valerie Ordinario, Rialyn Rojo, Feroni Panjaitan, Marvin John Pua, Stefanie Lim-Uy, Jay Datukan, Rolando Lopez, Teofilo San Luis

Pulmonry sclerosing pneumocytoma of the lung with spindle stromal cells: A potential pitfall in biopsy specimen.

Lee Fong Wan, et al.

Five-year survival of Filipino women with invasive breast cancers according to clinical stages and immunohistochemistry-based molecular subtypes: a retrospective cohort study. JSCO 2018.

Ando M, Uson AJ

Malignant Melanoma of the Palate: Report of a Metastatic Case.

Mel Valerie Cruz-Ordinario, C.A.D.G. Boado, A.E. Gorospe

Preoperative concurrent CAPOX-radiotherapy in Thai locally advanced rectal cancer patients.

Ekaphop Sirachainan

Peripheral blood quantitative PCR analysis of EBV DNA in nasopharyngeal carcinoma

Ekaphop Sirachainan

書籍

Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004; 60(4): 1120-1126.

Igaki H, Tokuuye K, Okumura T, Sugahara S, Kagei K, Hata M, Ohara K, Hashimoto T, Tsuboi K, Takano S, Matsumura A, Akine Y

PAGE TOP